0000773840-20-000048 | 10-Q | XBRL Viewer | Honeywell International INC

COMMITMENTS AND CONTINGENCIES 4 (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2013	Dec. 31, 2006	Dec. 31, 2002
Asbestos Related Liabilities [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Loss Contingency Accrual	$ 2,206	$ 2,357
Loss Contingency, Receivable	416	434
Bendix Asbestos Loss Contingency Liability [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Loss Contingency Accrual	1,401	1,499
Loss Contingency, Receivable	143	153
Narco Asbestos Loss Contingency Liability [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Loss Contingency Accrual	805	858
Loss Contingency, Receivable	273	$ 281
Estimated liability					$ 3,200
Change in NARCO Trust liability.				$ (207)
Annual Trust Cap	145
Exceptions To Cap [Abstract]
Value Not Included In Cap	100
Narco Asbestos Loss Contingency Liability [Member] \| Minimum [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Estimated liability				743
Narco Asbestos Loss Contingency Liability [Member] \| Maximum [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Estimated liability				961
Pre-bankruptcy NARCO Liability [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Loss Contingency Accrual	145
Estimated liability					2,200
Change in NARCO Trust liability.	(2,000)
NARCO Trust Liability [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Loss Contingency Accrual	660
Estimated liability			$ 743	$ 743	950
Other NARCO bankruptcy-related obligations [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Estimated liability					$ 73
Annual Contribution Claims [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Change in NARCO Trust liability.	(83)
Exceptions To Cap [Abstract]
Settlement payments	$ 54

ACCOUNTS RECEIVABLE - NET (Tables)

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Schedule of Accounts Receivables


	September 30, 2020		December 31, 2019
Trade	$	7,064	$	7,639
Less - Allowance for doubtful accounts	(186)		(146)
	$	6,878	$	7,493

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 5. Income Taxes The effective tax rate was lower than the U.S. federal statutory rate of 21% and decreased during 2020 compared to 2019 primarily due to the favorable resolution of a foreign tax matter related to the previously completed spin-off transactions, tax law changes in India, and the resolution of certain U.S. tax matters offset by a non-cash charge related to the reduction of the aggregate carrying value of certain receivables with no corresponding tax benefit.

SEGMENT FINANCIAL DATA 2 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
SEGMENT FINANCIAL DATA 2 (Details) - USD ($) $ in Millions	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment profit	$ 1,553	$ 1,928	$ 4,786	$ 5,707
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Interest and other financial charges	(101)	(96)	(264)	(266)
Repositioning and other charges	(144)	(96)	(486)	(306)
Income before taxes	1,148	1,967	4,302	5,791
Segment Reconciling Items [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Interest and other financial charges	(101)	(96)	(264)	(266)
Stock compensation expense	(40)	(37)	(118)	(112)
Repositioning and other charges	(144)	(96)	(486)	(306)
Other	(330)	106	(249)	284
Income before taxes	1,148	1,967	4,302	5,791
Segment Reconciling Items [Member] \| Pension [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Pension ongoing income	197	150	593	449
Segment Reconciling Items [Member] \| Other Postretirement [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Pension ongoing income	13	12	40	35
Corporate
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment profit	(7)	(54)	(73)	(202)
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Repositioning and other charges	$ (33)	$ (22)	$ (77)	$ (123)

DOCUMENT AND ENTITY INFORMATION	9 Months Ended
DOCUMENT AND ENTITY INFORMATION	Sep. 30, 2020 shares
Cover [Abstract]
Document type	10-Q
Document Quarterly Report	true
Document period end date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	1-8974
Entity registrant name	Honeywell International Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-2640650
Entity Address, Address Line One	300 South Tryon Street
Entity Address, City or Town	Charlotte,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28202
City Area Code	704
Local Phone Number	627-6200
Entity Listings [Line Items]
Entity current reporting status	Yes
Entity Interactive Data Current	Yes
Entity filer category	Large Accelerated Filer
Document Fiscal Year Focus	2020
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity common stock shares outstanding	701,685,768
Document Fiscal Period Focus	Q3
Current fiscal year end date	--12-31
Amendment flag	false
Entity central index key	0000773840
Common Stock [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, par value $1 per share*
Trading Symbol	HON
NEW YORK STOCK EXCHANGE	NYSE
1.300% Senior Notes due 2023 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	1.300% Senior Notes due 2023
Trading Symbol	HON 23A
NEW YORK STOCK EXCHANGE	NYSE
0.000% Senior Notes due 2024 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	0.000% Senior Notes due 2024
Trading Symbol	HON 24A
NEW YORK STOCK EXCHANGE	NYSE
2.250% Senior Notes due 2028 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	2.250% Senior Notes due 2028
Trading Symbol	HON 28A
NEW YORK STOCK EXCHANGE	NYSE
0.750% Senior Notes due 2032 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	0.750% Senior Notes due 2032
Trading Symbol	HON 32
NEW YORK STOCK EXCHANGE	NYSE

OTHER (INCOME) EXPENSE (Details) - USD ($)	3 Months Ended		9 Months Ended
OTHER (INCOME) EXPENSE (Details) - USD ($)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Other Income and Expenses [Line Items]
Interest Income	$ (20,000,000)	$ (64,000,000)	$ (86,000,000)	$ (194,000,000)
Equity income of affiliated companies	(17,000,000)	(13,000,000)	(44,000,000)	(33,000,000)
Loss (gain) on sale of non-strategic business and assets	0	0	0	(1,000,000)
Foreign exchange	(1,000,000)	(43,000,000)	(16,000,000)	(97,000,000)
Reimbursement Receivables Charge	350,000,000	0	350,000,000	0
Other net	1,000,000	1,000,000	1,000,000	8,000,000
Other (Income) Expense, Total	62,000,000	(311,000,000)	(546,000,000)	(901,000,000)
Pension Plans, Defined Benefit [Member]
Other Income and Expenses [Line Items]
Ongoing income - non-service	(238,000,000)	(180,000,000)	(711,000,000)	(549,000,000)
Other Postretirement Benefits Plans, Defined Benefit [Member]
Other Income and Expenses [Line Items]
Ongoing income - non-service	$ (13,000,000)	$ (12,000,000)	$ (40,000,000)	$ (35,000,000)

SEGMENT FINANCIAL DATA (Details) $ in Millions	3 Months Ended		9 Months Ended
SEGMENT FINANCIAL DATA (Details) $ in Millions	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)
Segment Reporting Information [Line Items]
Number of Operating Segments			4
Net Sales	$ 7,797	$ 9,086	$ 23,737	$ 27,213
Total segment profit	1,553	1,928	4,786	5,707
Products [Member]
Segment Reporting Information [Line Items]
Net Sales	5,885	6,793	17,933	20,496
Services [Member]
Segment Reporting Information [Line Items]
Net Sales	1,912	2,293	5,804	6,717
Corporate
Segment Reporting Information [Line Items]
Total segment profit	(7)	(54)	(73)	(202)
Aerospace
Segment Reporting Information [Line Items]
Net Sales	2,662	3,544	8,566	10,393
Aerospace \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales	2,662	3,544	8,566	10,393
Total segment profit	617	908	2,082	2,653
Aerospace \| Operating Segments [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Net Sales	1,623	2,213	5,335	6,462
Aerospace \| Operating Segments [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Net Sales	1,039	1,331	3,231	3,931
Honeywell Building Technologies
Segment Reporting Information [Line Items]
Net Sales	1,305	1,415	3,763	4,254
Honeywell Building Technologies \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales	1,305	1,415	3,763	4,254
Total segment profit	282	297	794	868
Honeywell Building Technologies \| Operating Segments [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Net Sales	972	1,091	2,807	3,283
Honeywell Building Technologies \| Operating Segments [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Net Sales	333	324	956	971
Performance Materials and Technologies
Segment Reporting Information [Line Items]
Net Sales	2,252	2,670	6,867	7,977
Performance Materials and Technologies \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales	2,252	2,670	6,867	7,977
Total segment profit	442	582	1,373	1,790
Performance Materials and Technologies \| Operating Segments [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Net Sales	1,803	2,129	5,510	6,437
Performance Materials and Technologies \| Operating Segments [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Net Sales	449	541	1,357	1,540
Safety and Productivity Solutions
Segment Reporting Information [Line Items]
Net Sales	1,578	1,457	4,541	4,589
Safety and Productivity Solutions \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales	1,578	1,457	4,541	4,589
Total segment profit	219	195	610	598
Safety and Productivity Solutions \| Operating Segments [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Net Sales	1,487	1,360	4,281	4,314
Safety and Productivity Solutions \| Operating Segments [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Net Sales	$ 91	$ 97	$ 260	$ 275

COMMITMENTS AND CONTINGENCIES 5 (Details) - Bendix Asbestos Loss Contingency Liability [Member] - claim	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018
Loss Contingency Claims [Abstract]
Claims unresolved at the beginning of period	6,480	6,209	6,280
Claims filed during the period	1,621	2,659	2,430
Claims resolved during the period	(1,680)	(2,388)	(2,501)
Claims unresolved at the end of period	6,421	6,480	6,209

REPOSITIONING AND OTHER CHARGES 5 (Details)	9 Months Ended
REPOSITIONING AND OTHER CHARGES 5 (Details)	Sep. 30, 2020 USD ($)
Restructuring Reserve [Line Items]
Balance at beginning of period,	$ 651,000,000
Charges	491,000,000
Usage - cash	(399,000,000)
Usage - noncash	(11,000,000)
Foreign currency translation	9,000,000
Adjustments	(42,000,000)
Balance at end of period,	699,000,000
Severance
Restructuring Reserve [Line Items]
Balance at beginning of period,	555,000,000
Charges	433,000,000
Usage - cash	(343,000,000)
Usage - noncash	0
Foreign currency translation	9,000,000
Adjustments	(40,000,000)
Balance at end of period,	614,000,000
Asset impairments
Restructuring Reserve [Line Items]
Balance at beginning of period,	0
Charges	11,000,000
Usage - cash	0
Usage - noncash	(11,000,000)
Foreign currency translation	0
Adjustments	0
Balance at end of period,	0
Exit costs
Restructuring Reserve [Line Items]
Balance at beginning of period,	96,000,000
Charges	47,000,000
Usage - cash	(56,000,000)
Usage - noncash	0
Foreign currency translation	0
Adjustments	(2,000,000)
Balance at end of period,	$ 85,000,000

COMMITMENTS AND CONTINGENCIES 7 (Details) - $ / claims	12 Months Ended
COMMITMENTS AND CONTINGENCIES 7 (Details) - $ / claims	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Resolution Values Per Claim [Line Items]
Malignant claims	50,200	55,300	56,000	44,000	44,000
Nonmalignant claims	3,900	4,700	2,800	4,485	100

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer [Text Block]

Note 7. Revenue Recognition and Contracts with Customers

Honeywell generates revenue from a comprehensive offering of products and services, including software and technologies, that are sold to a variety of customers in multiple end markets. See the following table and related discussions by operating segment for details.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Aerospace
Commercial Aviation Original Equipment	$	406	$	772	$	1,527	$	2,265
Commercial Aviation Aftermarket	774		1,452		2,807		4,234
Defense and Space	1,482		1,320		4,232		3,894
	2,662		3,544		8,566		10,393
Honeywell Building Technologies
Products	751		823		2,163		2,476
Building Solutions	554		592		1,600		1,778
	1,305		1,415		3,763		4,254
Performance Materials and Technologies
UOP	461		717		1,572		2,030
Process Solutions	1,135		1,283		3,379		3,818
Specialty Products	261		256		786		790
Fluorine Products	395		414		1,130		1,339
	2,252		2,670		6,867		7,977
Safety and Productivity Solutions
Safety and Retail	599		558		1,612		1,653
Productivity Solutions and Services	322		307		877		926
Warehouse and Workflow Solutions	445		383		1,457		1,361
Sensing & Internet-of-Things (IoT)	212		209		595		649
	1,578		1,457		4,541		4,589
Net sales	$	7,797	$	9,086	$	23,737	$	27,213

Aerospace – A global supplier of products, software and services for aircrafts that it sells to original equipment manufacturers (OEM) and other customers in a variety of end markets including: air transport, regional, business and general aviation aircraft, airlines, aircraft operators and defense and space contractors. Aerospace products and services include auxiliary power units, propulsion engines, environmental control systems, integrated avionics, wireless connectivity services, electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, management and technical services, advanced systems and instruments, satellite and space components, aircraft wheels and brakes, repair and overhaul services and thermal systems. Aerospace also provides spare parts, repair, overhaul and maintenance services (principally to aircraft operators) for the aftermarket. Honeywell Forge solutions are designed to identify and resolve problems faster, making fleet management and flight operations more efficient.

Honeywell Building Technologies – A global provider of products, software, solutions and technologies that enable building owners and occupants to ensure their facilities are safe, energy efficient, sustainable and productive. Honeywell Building Technologies products and services include advanced software applications for building control and optimization; sensors, switches, control systems and instruments for energy management; access control; video surveillance; fire products; remote patient monitoring systems; and installation, maintenance and upgrades of systems. Honeywell Forge solutions are designed to digitally manage buildings to use space intelligently, cut operating expenses and reduce maintenance.

Performance Materials and Technologies – A global provider in developing and manufacturing high-quality performance chemicals and materials, process technologies and automation solutions, including Honeywell Forge connected solutions. The segment comprises UOP, Process Solutions and Advanced Materials. UOP provides process technology, products, including catalysts and adsorbents, equipment, and consulting services that enable customers to efficiently produce gasoline, diesel, jet fuel, petrochemicals and renewable fuels for the petroleum refining, gas processing, petrochemical, and other industries. Process Solutions provides automation control, instrumentation, advanced software and related services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, and metals, minerals and mining industries. Through its smart energy products, Process Solutions enables utilities and distribution companies to deploy advanced capabilities to improve operations, reliability and environmental sustainability. Advanced Materials manufactures a wide variety of high-performance products, including materials used to manufacture end products such as bullet-resistant armor, nylon, computer chips and pharmaceutical packaging, and provides reduced and low global-warming-potential (GWP) materials based on hydrofluoro-olefin technology. In the industrial environment, Honeywell Forge solutions enable integration and connectivity to provide a holistic view of operations and turn data into clear actions to maximize productivity and efficiency. Honeywell Forge's cybersecurity capabilities help identify risks and act on cyber-related incidents, together enabling improved operations and protecting processes, people and assets.

Safety and Productivity Solutions – A global provider of products and software that improve productivity, workplace safety and asset performance to customers around the globe. Safety products include personal protection equipment, apparel, gear, and footwear designed for work, play and outdoor activities; gas detection technology; and cloud-based notification and emergency messaging. Productivity Solutions products and services include mobile devices and software for computing, data collection and thermal printing; supply chain and warehouse automation equipment, software and solutions; custom-engineered sensors, switches and controls for sensing and productivity solutions; and software-based data and asset management productivity solutions. Honeywell Forge solutions digitally automate processes to improve efficiency while reducing downtime and safety costs.

For a summary by disaggregated product and services sales for each segment, refer to Note 14 Segment Financial Data of Notes to Consolidated Financial Statements.

The Company recognizes revenues from performance obligations to customers that are satisfied at a point in time and over time. The disaggregation of the Company's revenue based off timing of recognition is as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Products, transferred point in time	61	%	62	%	61	%	61	%
Products, transferred over time	15		13		15		14
Net product sales	76		75		76		75
Services, transferred point in time	7		8		8		9
Services, transferred over time	17		17		16		16
Net service sales	24		25		24		25
Net sales	100	%	100	%	100	%	100	%

Contract Balances

The Company records progress on satisfying performance obligations to customers, and the related billings and cash collections, on the Consolidated Balance Sheet in Accounts receivable - net and Other assets (unbilled receivables (contract assets) and billed receivables) and Accrued liabilities and Other liabilities (customer advances and deposits (contract liabilities)). Unbilled receivables (contract assets) arise when the timing of cash collected from customers differs from the timing of revenue recognition, such as when contract provisions require specific milestones to be met before a customer can be billed. Unbilled receivable balance increases when the revenue associated with the contract is recognized prior to billing and decreases when billed in accordance with the terms of the contract. Contract liabilities increases when customers remit contractual cash payments in advance of the Company satisfying performance obligations under contractual arrangements, including those with performance obligations to be satisfied over a period of time. Contract liabilities decreases when revenue is recorded, either when a milestone is met triggering the contractual right to bill or when the performance obligation is satisfied.

Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period.

The following table summarizes the Company's contract assets and liabilities balances:


	2020		2019
Contract assets - January 1	$	1,602	$	1,548
Contract assets - September 30	1,819		1,812
Change in contract assets - increase (decrease)	$	217	$	264

Contract liabilities - January 1	$	(3,501)	$	(3,378)
Contract liabilities - September 30	(3,666)		(3,188)
Change in contract liabilities - decrease (increase)	$	(165)	$	190

Net change	$	52	$	454

The net change for the nine months ended September 30, 2020 and September 30, 2019 was primarily driven by the recognition of revenue associated with respective contracts prior to billing.

For the three and nine months ended September 30, 2020, the Company recognized revenue of $351 million and $1,554 million that was previously included in the beginning balance of contract liabilities. For the three and nine months ended September 30, 2019, the Company recognized revenue of $215 million and $1,195 million that was previously included in the beginning balance of contract liabilities.

When contracts are modified to account for changes in contract specifications and requirements, the Company considers whether the modification either creates new or changes the existing enforceable rights and obligations. Contract modifications that are for goods or services that are not distinct from the existing contract, due to the significant integration with the original good or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification on the transaction price and the Company's measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. When the modifications include additional performance obligations that are distinct and at relative stand-alone selling price, they are accounted for as a new contract and performance obligation, which are recognized prospectively.

Performance Obligations

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is defined as the unit of account. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When the Company's contracts with customers require highly complex integration or manufacturing services that are not separately identifiable from other promises in the contracts and, therefore, not distinct, then the entire contract is accounted for as a single performance obligation. In situations when the Company's contract includes distinct goods or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct goods or services. For any contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on the estimated relative standalone selling price of each distinct good or service in the contract. For product sales, each product sold to a customer typically represents a distinct performance obligation. In such cases, the observable standalone sales are used to determine the standalone selling price.

Performance obligations are satisfied as of a point in time or over time. Performance obligations are supported by contracts with customers, providing a framework for the nature of the distinct goods, services or bundle of goods and services. The timing of satisfying the performance obligation is typically indicated by the terms of the contract.

The following table outlines the Company's remaining performance obligations disaggregated by segment:


	September 30, 2020
Aerospace	$	9,717
Honeywell Building Technologies	5,537
Performance Materials and Technologies	6,532
Safety and Productivity Solutions	3,858
	$	25,644

Performance obligations recognized as of September 30, 2020 will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 54% and 46%, respectively.

The timing of satisfaction of the Company's performance obligations does not significantly vary from the typical timing of payment. Typical payment terms of the Company's fixed-price over time contracts include progress payments based on specified events or milestones, or based on project progress. For some contracts we may be entitled to receive an advance payment.

The Company has applied the practical expedient for certain revenue streams to exclude the value of remaining performance obligations for (i) contracts with an original expected term of one year or less or (ii) contracts for which we recognize revenue in proportion to the amount we have the right to invoice for services performed.

LEASES

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Lessee, Operating Leases [Text Block]

Note 10. Leases

The Company's operating and finance lease portfolio is described in Note 14, Leases of the Notes to its Consolidated Financial Statements in our 2019 Annual Report on Form 10-K.

Supplemental cash flow information related to leases was as follows:


	Nine Months Ended September 30,
		2020	2019
Net right-of-use assets obtained in exchange for lease obligations:
Operating leases		155	118
Finance leases		24	17

Supplemental balance sheet information related to leases was as follows:


	September 30, 2020		December 31, 2019
Operating leases
Other assets	$	725	$	673
Accrued liabilities	179		171
Other liabilities	597		534
Total operating lease liabilities	$	776	$	705
Financing leases
Property, plant and equipment	$	360	$	361
Accumulated depreciation	(171)		(152)
Property, plant and equipment - net	$	189	$	209
Current maturities of long-term debt	61		59
Long-term debt	135		156
Total financing lease liabilities	$	196	$	215

OTHER (INCOME) EXPENSE

9 Months Ended

Sep. 30, 2020

Other Income and Expenses [Abstract]

Other (Income) expense [Text Block]

Note 4. Other (Income) Expense


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Interest income	$	(20)	$	(64)	$	(86)	$	(194)
Pension ongoing income – non-service	(238)		(180)		(711)		(549)
Other postretirement income – non-service	(13)		(12)		(40)		(35)
Equity income of affiliated companies	(17)		(13)		(44)		(33)

Loss (gain) on sale of non-strategic business and assets	—		—		—		(1)
Foreign exchange	(1)		(43)		(16)		(97)
Reimbursement receivables charge	350		—		350		—
Other (net)	1		1		1		8
	$	62	$	(311)	$	(546)	$	(901)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Sep. 30, 2020
Accounting Policies [Abstract]
Reclassifications	Reclassifications—Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements	Recent Accounting Pronouncements—The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated results of operations, financial position and cash flows (Consolidated Financial Statements). In December 2019, the FASB issued an accounting standard update to simplify the accounting for income taxes. The standard's amendments include changes in various subtopics of accounting for income taxes including, but not limited to, accounting for "hybrid" tax regimes, tax basis step-up in goodwill obtained in a transaction that is not a business combination, intraperiod tax allocation exception to incremental approach, ownership changes in investments, interim-period accounting for enacted changes in tax law, and year-to-date loss limitation in interim-period tax accounting. The guidance is effective for fiscal years beginning after December 15, 2020 with early adoption permitted, including the interim periods within those years. The Company is currently evaluating impacts of these amendments on the Company's Consolidated Financial Statements, and related notes to the Financial Statements. The Company does not expect the adoption of this standard to have a material impact on the Company's Consolidated Financial Statements. In June 2016, the FASB issued an accounting standard that requires companies to utilize an impairment model (current expected credit loss, or CECL) for most financial assets measured at amortized cost and certain other financial instruments, which include, but are not limited to, trade and other receivables. This accounting standard replaced the incurred loss model with a model that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to estimate those losses. Effective January 1, 2020, the Company adopted this standard. The adoption of this standard did not have a material impact on the Company's Consolidated Financial Statements.

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES 3 (Details) - Long-term Debt [Member] - Designated as Hedging Instrument [Member] - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying Amount of the Hedged Item	$ 4,180	$ 3,975
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item	$ 230	$ 25

REPOSITIONING AND OTHER CHARGES 3 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 144	$ 96	$ 486	$ 306
Corporate
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	33	22	77	123
Aerospace
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	33	12	151	32
Honeywell Building Technologies
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	29	28	87	36
Performance Materials and Technologies
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	34	28	139	61
Safety and Productivity Solutions
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 15	$ 6	$ 32	$ 54

COMMITMENTS AND CONTINGENCIES 3 (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Insurance recoveries for asbestos related liabilities	$ 374	$ 392
Asbestos related liabilities	1,845	1,996
Asbestos Related Liabilities [Member]
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Other current assets	42	42
Insurance recoveries for asbestos related liabilities	374	392
Total assets	416	434
Accrued liabilities	361	361
Asbestos related liabilities	1,845	1,996
Total liabilities	$ 2,206	$ 2,357

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 3,486,000,000	$ 4,640,000,000
Less: Net income attributable to the noncontrolling interest	66,000,000	59,000,000
Net income attributable to Honeywell	3,420,000,000	4,581,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation	480,000,000	500,000,000
Amortization	268,000,000	319,000,000
Repositioning and other charges	486,000,000	306,000,000
Net payments for repositioning and other charges	(652,000,000)	(157,000,000)
Pension and other postretirement income	(633,000,000)	(484,000,000)
Pension and other postretirement benefit payments	(37,000,000)	(50,000,000)
Stock compensation expense	118,000,000	112,000,000
Deferred income taxes	(289,000,000)	(298,000,000)
Reimbursement receivables charge	350,000,000	0
Other	(369,000,000)	98,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts receivable	615,000,000	(78,000,000)
Inventories	(284,000,000)	(276,000,000)
Other current assets	246,000,000	(68,000,000)
Accounts payable	(460,000,000)	(89,000,000)
Accrued liabilities	167,000,000	(133,000,000)
Net cash provided by (used for) operating activities	3,426,000,000	4,283,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(615,000,000)	(504,000,000)
Proceeds from disposals of property, plant and equipment	17,000,000	41,000,000
Increase in investments	(2,371,000,000)	(3,218,000,000)
Decrease in investments	2,634,000,000	3,318,000,000
Receipts (payments) from settlements of derivative contracts	(75,000,000)	245,000,000
Other	0	(4,000,000)
Net cash provided by (used for) investing activities	(410,000,000)	(122,000,000)
Cash flows from financing activities:
Proceeds from issuance of commercial paper and other short-term borrowings	8,577,000,000	10,292,000,000
Payments of commercial paper and other short-term borrowings	(8,512,000,000)	(10,293,000,000)
Proceeds from issuance of common stock	163,000,000	425,000,000
Proceeds from issuance of long-term debt	10,105,000,000	2,725,000,000
Payments of long-term debt	(4,237,000,000)	(120,000,000)
Repurchases of common stock	(2,149,000,000)	(3,650,000,000)
Cash dividends paid	(1,921,000,000)	(1,798,000,000)
Other	(54,000,000)	(72,000,000)
Net cash provided by (used for) financing activities	1,972,000,000	(2,491,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(19,000,000)	(49,000,000)
Net increase (decrease) in cash and cash equivalents	4,969,000,000	1,621,000,000
Cash and cash equivalents at beginning of period	9,067,000,000	9,287,000,000
Cash and cash equivalents at end of period	$ 14,036,000,000	$ 10,908,000,000

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table sets forth the Company’s financial assets and liabilities accounted for at fair value on a recurring basis:


	September 30, 2020		December 31, 2019
Assets:
Foreign currency exchange contracts	$	357	$	291
Available for sale investments	1,160		1,523
Interest rate swap agreements	230		38
Cross currency swap agreements	10		51
Liabilities:
Foreign currency exchange contracts	$	34	$	21
Interest rate swap agreements	—		13

Financial assets and liabilities that were not carried at fair value

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:


	September 30, 2020				December 31, 2019
	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets
Long-term receivables	$	148	$	143	$	129	$	127
Liabilities
Long-term debt and related current maturities	$	18,672	$	20,084	$	12,486	$	13,578

Amounts recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges [Table Text Block]

The following table sets forth the amounts on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:


Line in the Consolidated Balance Sheet of Hedged Item	Carrying Amount of the Hedged Item				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item
	September 30, 2020		December 31, 2019		September 30, 2020		December 31, 2019
Long-term debt	$	4,180	$	3,975	$	230	$	25

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]

The following tables summarize the location and impact to the Consolidated Statement of Operations related to fair value and cash flow hedging relationships:


	Three Months Ended September 30, 2020
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense		Interest and Other Financial Charges
	$	7,797	$	4,315	$	1,103	$	62	$	101
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income	(1)		(1)		(1)		(35)		—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		4		—		8		—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items	—		—		—		—		13
Derivatives designated as hedges	—		—		—		—		(13)


	Three Months Ended September 30, 2019
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense		Interest and Other Financial Charges
	$	9,086	$	4,775	$	1,296	$	(311)	$	96
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income	1		9		—		53		—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		6		—		9		—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items	—		—		—		—		(55)
Derivatives designated as hedges	—		—		—		—		55


	Nine Months Ended September 30, 2020
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense	Interest and Other Financial Charges
	$	23,737	$	12,852	$	3,524	(546)	$	264
Gain or (loss) on cash flow hedges:
Foreign currency exchange contracts:
Amount reclassified from accumulated other comprehensive income into income	(2)		29		(4)		(37)	—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		12		—		25	—
Gain or (loss) on fair value hedges:
Interest rate swap agreements:
Hedged items	—		—		—		—	(206)
Derivatives designated as hedges	—		—		—		—	206


	Nine Months Ended September 30, 2019
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense		Interest and Other Financial Charges
	$	27,213	$	14,244	$	4,046	$	(901)	$	266
Gain or (loss) on cash flow hedges:
Foreign currency exchange contracts:
Amount reclassified from accumulated other comprehensive income into income	2		33		1		77		—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		17		—		27		—
Gain or (loss) on fair value hedges:
Interest rate swap agreements:
Hedged items	—		—		—		—		(118)
Derivatives designated as hedges	—		—		—		—		118

Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The following table summarizes the amounts of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss):


	Three Months Ended September 30,				Nine Months Ended September 30,
Derivatives Net Investment Hedging Relationships	2020		2019		2020		2019
Euro-denominated long-term debt	$	(126)	$	131	$	(64)	$	157
Euro-denominated commercial paper	(25)		136		30		163
Cross currency swap	(42)		39		(61)		44
Foreign currency exchange contracts	(28)		23		(46)		28

REPOSITIONING AND OTHER CHARGES 4 (Details) $ in Millions	3 Months Ended		9 Months Ended
REPOSITIONING AND OTHER CHARGES 4 (Details) $ in Millions	Sep. 30, 2020 USD ($) Employees	Sep. 30, 2019 USD ($) Employees	Sep. 30, 2020 USD ($) Employees	Sep. 30, 2019 USD ($) Employees
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 124	$ 86	$ 449	$ 228
Net repositioning and other charges Paragraph Details [Abstract]
Gross Repositioning Charge	$ 135	$ 89	$ 491	$ 235
Number of employees severed \| Employees	3,113	1,123	13,042	3,436
Severance
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 113	$ 41	$ 433	$ 147
Asset impairments
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	5	15	11	26
Exit costs
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	32	21	32	21
Restructuring and Related Cost, Incurred Cost	17	33	47	62
Reserve adjustments
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	$ (11)	$ (3)	$ (42)	$ (7)

INVENTORIES (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 1,081,000,000	$ 1,056,000,000
Work in process	850,000,000	817,000,000
Finished products	2,774,000,000	2,593,000,000
Inventory, Gross	4,705,000,000	4,466,000,000
Reduction to LIFO cost basis	0	(45,000,000)
Inventories	$ 4,705,000,000	$ 4,421,000,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies [Text Block]	Note 2. Summary of Significant Accounting Policies The accounting policies of the Company are set forth in Note 1 to the Company's Consolidated Financial Statements contained in the Company’s 2019 Annual Report on Form 10-K. The Company includes herein certain updates to those policies. Reclassifications—Certain prior year amounts have been reclassified to conform to the current year presentation. Recent Accounting Pronouncements—The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated results of operations, financial position and cash flows (Consolidated Financial Statements). In December 2019, the FASB issued an accounting standard update to simplify the accounting for income taxes. The standard's amendments include changes in various subtopics of accounting for income taxes including, but not limited to, accounting for "hybrid" tax regimes, tax basis step-up in goodwill obtained in a transaction that is not a business combination, intraperiod tax allocation exception to incremental approach, ownership changes in investments, interim-period accounting for enacted changes in tax law, and year-to-date loss limitation in interim-period tax accounting. The guidance is effective for fiscal years beginning after December 15, 2020 with early adoption permitted, including the interim periods within those years. The Company is currently evaluating impacts of these amendments on the Company's Consolidated Financial Statements, and related notes to the Financial Statements. The Company does not expect the adoption of this standard to have a material impact on the Company's Consolidated Financial Statements. In June 2016, the FASB issued an accounting standard that requires companies to utilize an impairment model (current expected credit loss, or CECL) for most financial assets measured at amortized cost and certain other financial instruments, which include, but are not limited to, trade and other receivables. This accounting standard replaced the incurred loss model with a model that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to estimate those losses. Effective January 1, 2020, the Company adopted this standard. The adoption of this standard did not have a material impact on the Company's Consolidated Financial Statements.

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES 2 (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt	$ 18,672	$ 12,486
Carrying Value [Member] \| Significant Observable Inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term receivables	148	129
Long-term debt and related current maturities	18,672	12,486
Estimated Fair Value [Member] \| Significant Observable Inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term receivables	143	127
Long-term debt and related current maturities	$ 20,084	$ 13,578

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Financial Instruments and Fair Value Measures

Note 12. Financial Instruments and Fair Value Measures

Our credit, market, foreign currency and interest rate risk management policies are described in Note 15, Financial Instruments and Fair Value Measures of Notes to Consolidated Financial Statements in our 2019 Annual Report on Form 10-K.

The following table sets forth the Company’s financial assets and liabilities accounted for at fair value on a recurring basis:


	September 30, 2020		December 31, 2019
Assets:
Foreign currency exchange contracts	$	357	$	291
Available for sale investments	1,160		1,523
Interest rate swap agreements	230		38
Cross currency swap agreements	10		51
Liabilities:
Foreign currency exchange contracts	$	34	$	21
Interest rate swap agreements	—		13

The foreign currency exchange contracts, interest rate swap agreements, and cross currency swap agreements are valued using broker quotations, or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within level 2. The Company also holds investments in commercial paper, certificates of deposits, and time deposits that are designated as available for sale and are valued using published prices based off observable market data. As such, these investments are classified within level 2. The Company also holds available for sale investments in U.S. government and corporate debt securities valued utilizing published prices based on quoted market pricing, which are classified within level 1.

The carrying value of cash and cash equivalents, trade accounts and notes receivables, payables, commercial paper (of which $694 million and $3,513 million was Euro denominated as of September 30, 2020 and December 31, 2019, respectively) and short-term borrowings approximates fair value.

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:


	September 30, 2020				December 31, 2019
	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets
Long-term receivables	$	148	$	143	$	129	$	127
Liabilities
Long-term debt and related current maturities	$	18,672	$	20,084	$	12,486	$	13,578

The following table sets forth the amounts on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:


Line in the Consolidated Balance Sheet of Hedged Item	Carrying Amount of the Hedged Item				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item
	September 30, 2020		December 31, 2019		September 30, 2020		December 31, 2019
Long-term debt	$	4,180	$	3,975	$	230	$	25

The Company determined the fair value of the long-term receivables by utilizing transactions in the listed markets for identical or similar assets. As such, the fair value of these receivables is considered level 2. The Company determined the fair value of the long-term debt and related current maturities utilizing transactions in the listed markets for identical or similar liabilities. As such, the fair value of the long-term debt and related current maturities is considered level 2.

Interest rate swap agreements are designated as hedge relationships with gains or losses on the derivative recognized in Interest and other financial charges offsetting the gains and losses on the underlying debt being hedged. For the three and nine months ended September 30, 2020, we recognized $13 million of expense and $206 million of gains in earnings on interest rate swap agreements. For the three and nine months ended September 30, 2019, the Company recognized $55 million and $118 million of gains in earnings on interest rate swap agreements. Gains and losses are fully offset by losses and gains on the underlying debt being hedged.

The Company economically hedges its exposure to changes in foreign exchange rates principally with forward contracts. These contracts are marked-to-market with the resulting gains and losses recognized in earnings offsetting the gains and losses on the non-functional currency denominated monetary assets and liabilities being hedged. For the three and nine months ended September 30, 2020, we recognized $136 million and $69 million of expense in Other (income) expense. For the three and nine months ended September 30, 2019, the Company recognized $182 million and $231 million of income in Other (income) expense. As of September 30, 2020, cash collateral received that has not been offset against our derivatives of $323 million was recorded in Accrued liabilities and Other assets.

The following tables summarize the location and impact to the Consolidated Statement of Operations related to fair value and cash flow hedging relationships:


	Three Months Ended September 30, 2020
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense		Interest and Other Financial Charges
	$	7,797	$	4,315	$	1,103	$	62	$	101
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income	(1)		(1)		(1)		(35)		—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		4		—		8		—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items	—		—		—		—		13
Derivatives designated as hedges	—		—		—		—		(13)


	Three Months Ended September 30, 2019
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense		Interest and Other Financial Charges
	$	9,086	$	4,775	$	1,296	$	(311)	$	96
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income	1		9		—		53		—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		6		—		9		—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items	—		—		—		—		(55)
Derivatives designated as hedges	—		—		—		—		55


	Nine Months Ended September 30, 2020
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense	Interest and Other Financial Charges
	$	23,737	$	12,852	$	3,524	(546)	$	264
Gain or (loss) on cash flow hedges:
Foreign currency exchange contracts:
Amount reclassified from accumulated other comprehensive income into income	(2)		29		(4)		(37)	—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		12		—		25	—
Gain or (loss) on fair value hedges:
Interest rate swap agreements:
Hedged items	—		—		—		—	(206)
Derivatives designated as hedges	—		—		—		—	206


	Nine Months Ended September 30, 2019
	Revenue		Cost of Products Sold		Selling, General and Administrative Expenses		Other (Income) Expense		Interest and Other Financial Charges
	$	27,213	$	14,244	$	4,046	$	(901)	$	266
Gain or (loss) on cash flow hedges:
Foreign currency exchange contracts:
Amount reclassified from accumulated other comprehensive income into income	2		33		1		77		—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	—		17		—		27		—
Gain or (loss) on fair value hedges:
Interest rate swap agreements:
Hedged items	—		—		—		—		(118)
Derivatives designated as hedges	—		—		—		—		118

The following table summarizes the amounts of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss):


	Three Months Ended September 30,				Nine Months Ended September 30,
Derivatives Net Investment Hedging Relationships	2020		2019		2020		2019
Euro-denominated long-term debt	$	(126)	$	131	$	(64)	$	157
Euro-denominated commercial paper	(25)		136		30		163
Cross currency swap	(42)		39		(61)		44
Foreign currency exchange contracts	(28)		23		(46)		28

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 14,036	$ 9,067
Short-term Investments	972	1,349
Accounts receivable - net	6,878	7,493
Inventories	4,705	4,421
Other current assets	1,609	1,973
Total current assets	28,200	24,303
Investments and long-term receivables	673	588
Property, plant and equipment - net	5,419	5,325
Goodwill	15,666	15,563
Other intangible assets - net	3,494	3,734
Insurance recoveries for asbestos related liabilities	374	392
Deferred income taxes	154	86
Other assets	9,479	8,688
Total assets	63,459	58,679
Current liabilities:
Accounts payable	5,270	5,730
Commercial paper and other short-term borrowings	3,550	3,516
Current maturities of long-term debt	985	1,376
Accrued liabilities	7,379	7,476
Total current liabilities	17,184	18,098
Long-term debt	17,687	11,110
Deferred income taxes	1,474	1,670
Postretirement benefit obligations other than pensions	309	326
Asbestos related liabilities	1,845	1,996
Other liabilities	6,640	6,766
Redeemable noncontrolling interest	7	7
SHAREOWNERS' EQUITY
Capital - common stock issued	958	958
Capital - additional paid in capital	7,155	6,876
Common stock held in treasury, at cost	(25,806)	(23,836)
Accumulated other comprehensive loss	(3,436)	(3,197)
Retained earnings	39,203	37,693
Total Honeywell shareowners' equity	18,074	18,494
Noncontrolling interest	239	212
Total shareowners' equity	18,313	18,706
Total liabilities, redeemable noncontrolling interest, and shareowners' equity	$ 63,459	$ 58,679

PENSION BENEFITS (Tables)

9 Months Ended

Sep. 30, 2020

Retirement Benefits [Abstract]

Defined Benefit Plans Disclosure

Net periodic pension benefit costs for the Company's significant defined benefit plans include the following components:


	U.S. Plans
	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Service cost	$	25	$	21	$	74	$	63
Interest cost	116		153		346		460
Expected return on plan assets	(284)		(279)		(851)		(837)
Amortization of prior service (credit)	(11)		(11)		(32)		(33)
	$	(154)	$	(116)	$	(463)	$	(347)


	Non-U.S. Plans
	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Service cost	$	6	$	4	$	17	$	16
Interest cost	26		34		78		106
Expected return on plan assets	(84)		(81)		(249)		(248)
Amortization of prior service (credit)	—		—		—		—
	$	(52)	$	(43)	$	(154)	$	(126)

ACCOUNTS RECEIVABLE - NET

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Accounts Receivable - Net

Note 8. Accounts Receivable - Net


	September 30, 2020		December 31, 2019
Trade	$	7,064	$	7,639
Less - Allowance for doubtful accounts	(186)		(146)
	$	6,878	$	7,493

Trade receivables include $1,779 million and $1,586 million of unbilled balances under long-term contracts as of September 30, 2020 and December 31, 2019. These amounts are billed in accordance with the terms of the customer contracts to which they relate.

LONG-TERM DEBT AND CREDIT AGREEMENTS

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Long-term Debt

Note 11. Long-term Debt and Credit Agreements


	September 30, 2020		December 31, 2019

0.65% Euro notes due 2020	$	—	$	1,123
4.25% notes due 2021	800		800
1.85% notes due 2021	1,500		1,500
0.483% notes due 2022	2,500		—
2.15% notes due 2022	600		600
Floating rate notes due 2022	1,100		600
1.30% Euro notes due 2023	1,454		1,404
3.35% notes due 2023	300		300
0.00% Euro notes due 2024	582		—
2.30% notes due 2024	750		750
1.35% notes due 2025	1,250		—
2.50% notes due 2026	1,500		1,500
2.25% Euro notes due 2028	872		842
2.70% notes due 2029	750		750
1.95% notes due 2030	1,000		—
0.75% Euro notes due 2032	582		—
5.70% notes due 2036	441		441
5.70% notes due 2037	462		462
5.375% notes due 2041	417		417
3.812% notes due 2047	445		445
2.80% notes due 2050	750		—
Industrial development bond obligations, floating rate maturing at various dates through 2037	22		22
6.625% debentures due 2028	201		201
9.065% debentures due 2033	51		51
Other (including capitalized leases and debt issuance costs), 8.0% weighted average maturing at various dates through 2025	343		278
	18,672		12,486
Less: current portion	(985)		(1,376)
	$	17,687	$	11,110

On August 19, 2020, the Company issued $2.5 billion 0.483% Senior Notes due 2022 and $500 million Floating Rate Senior Notes due 2022 (collectively, the “2022 Callable Notes”). The $500 million Floating Rate Senior Notes due 2022 were issued at a variable interest rate equal to the three-month LIBOR plus the applicable margin of 0.23%. The Company may redeem the 2022 fixed rate notes at any time and from time to time at our option in whole or in part, and the Company may redeem the 2022 floating rate notes at any time and from time to time on or after August 19, 2021 in whole or in part. The 2022 Callable Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with all of the Company's existing and future senior unsecured debt and senior to all of the Company's subordinated debt. The 2022 Callable Notes resulted in gross proceeds of $3.0 billion, offset by $10 million in discount and closing costs related to the offering. The Company used the proceeds of the offering to repay $3.0 billion of borrowings under the delayed draw term loan facility, referenced below.

On May 18, 2020, the Company issued $1.25 billion 1.35% Senior Notes due 2025, $1.0 billion 1.95% Senior Notes due 2030, and $750 million 2.80% Senior Notes due 2050 (collectively, the "2020 Notes") to replace $3.0 billion of undrawn commitments under the $6.0 billion delayed draw term loan facility, referenced below. The 2020 Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with all of the Company's existing and future senior unsecured debt and senior to the Company's subordinated debt. The offering provided gross proceeds of $3.0 billion, offset by $27 million in discount and closing costs related to the offering.

On March 10, 2020, the Company issued €500 million 0.00% Senior Notes due 2024 and €500 million 0.75% Senior Notes due 2032 (collectively, the "2020 Euro Notes"). The 2020 Euro Notes are senior unsecured and unsubordinated obligations of Honeywell and rank equally with all of Honeywell's existing and future senior unsecured debt and senior to all of Honeywell's subordinated debt. The offering provided gross proceeds of $1.1 billion, offset by $9 million in discount and closing costs related to the offering.

For issuances described above, unless otherwise noted, all debt issuance costs are deferred and recognized as a direct deduction to the related debt liability and are amortized to interest expense over the debt term.

On March 26, 2020, the Company entered into a Delayed Draw Term Loan Agreement (the “Term Loan Agreement”) with a syndicate of banks. The Term Loan Agreement provided for a two-year, delayed draw term loan facility in the aggregate principal amount of $6.0 billion. Effective May 22, 2020, the Company permanently reduced the undrawn commitments under the Term Loan Agreement by an aggregate amount of $3.0 billion. On June 24, 2020, the Company drew on the remaining $3.0 billion of commitments under the Term Loan Agreement at a variable interest rate equal to the one-month LIBOR plus the applicable margin of 1.25%. The draw provided gross proceeds of $3.0 billion offset by $7 million in closing costs related to the borrowing. On August 20, 2020 the Company prepaid the outstanding principal amount of $3.0 billion. As of September 30, 2020, there are no outstanding borrowings or commitments remaining under the Term Loan Agreement.

On February 21, 2020, the Company paid its 0.65% Euro notes due 2020.

On April 10, 2020, the Company entered into a $1.5 billion 364-Day Credit Agreement (the "364-Day Credit Agreement") with a syndicate of banks. This 364-Day Credit Agreement is maintained for general corporate purposes. The 364-Day Credit Agreement replaces the previously reported 364-day credit agreement dated as of April 26, 2019, which was terminated on April 10, 2020. As of September 30, 2020, there are no outstanding borrowings under the 364-Day Credit Agreement.

LEASES (Tables)

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Lease, Cost [Table Text Block]

.Supplemental cash flow information related to leases was as follows:


	Nine Months Ended September 30,
		2020	2019
Net right-of-use assets obtained in exchange for lease obligations:
Operating leases		155	118
Finance leases		24	17

Supplemental balance sheet information related to leases was as follows:


	September 30, 2020		December 31, 2019
Operating leases
Other assets	$	725	$	673
Accrued liabilities	179		171
Other liabilities	597		534
Total operating lease liabilities	$	776	$	705
Financing leases
Property, plant and equipment	$	360	$	361
Accumulated depreciation	(171)		(152)
Property, plant and equipment - net	$	189	$	209
Current maturities of long-term debt	61		59
Long-term debt	135		156
Total financing lease liabilities	$	196	$	215

OTHER (INCOME) EXPENSE (Tables)

9 Months Ended

Sep. 30, 2020

Other Income and Expenses [Abstract]

Other (income) expense [Table Text Block]


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Interest income	$	(20)	$	(64)	$	(86)	$	(194)
Pension ongoing income – non-service	(238)		(180)		(711)		(549)
Other postretirement income – non-service	(13)		(12)		(40)		(35)
Equity income of affiliated companies	(17)		(13)		(44)		(33)

Loss (gain) on sale of non-strategic business and assets	—		—		—		(1)
Foreign exchange	(1)		(43)		(16)		(97)
Reimbursement receivables charge	350		—		350		—
Other (net)	1		1		1		8
	$	62	$	(311)	$	(546)	$	(901)

LONG-TERM DEBT AND CREDIT AGREEMENTS (Details) € in Millions	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 EUR (€)	Dec. 31, 2019 USD ($)
Debt Instrument [Line Items]
Total long-term debt, including current portion	$ 18,672,000,000		$ 12,486,000,000
Less current portion	(985,000,000)		(1,376,000,000)
Long-term Debt and Lease Obligation	17,687,000,000		11,110,000,000
0.65% Euro notes due 2020 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 0		1,123,000,000
Debt Instrument, Interest Rate, Stated Percentage	0.65%	0.65%
4.25% notes due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 800,000,000		800,000,000
Debt Instrument, Interest Rate, Stated Percentage	4.25%	4.25%
1.85% notes due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,500,000,000		1,500,000,000
Debt Instrument, Interest Rate, Stated Percentage	1.85%	1.85%
0.483% notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 2,500,000,000		0
Debt Instrument, Interest Rate, Stated Percentage	0.483%	0.483%
2.15% notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 600,000,000		600,000,000
Debt Instrument, Interest Rate, Stated Percentage	2.15%	2.15%
Floating rate notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,100,000,000		600,000,000
Loans Receivable, Basis Spread on Variable Rate	0.23%	0.23%
Debt Instrument, Face Amount	$ 500,000,000
Term Loan Due 2022
Debt Instrument [Line Items]
Senior Notes	3,000,000,000.0
Gross proceeds	3,000,000,000.0
Discount and closing costs related to the offering	$ 7,000,000
Loans Receivable, Basis Spread on Variable Rate	1.25%	1.25%
Early Repayment of Senior Debt	$ 3,000,000,000.0
1.30% Euro notes due 2023 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,454,000,000		1,404,000,000
Debt Instrument, Interest Rate, Stated Percentage	1.30%	1.30%
3.35% notes due 2023 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 300,000,000		300,000,000
Debt Instrument, Interest Rate, Stated Percentage	3.35%	3.35%
0.00% Euro notes due 2024 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 582,000,000	€ 500	0
Debt Instrument, Interest Rate, Stated Percentage	0.00%	0.00%
2.30% notes due 2024 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 750,000,000		750,000,000
Debt Instrument, Interest Rate, Stated Percentage	2.30%	2.30%
1.35% notes due 2025 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,250,000,000		0
Debt Instrument, Interest Rate, Stated Percentage	1.35%	1.35%
2.50% notes due 2026 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,500,000,000		1,500,000,000
Debt Instrument, Interest Rate, Stated Percentage	2.50%	2.50%
2.25% Euro notes due 2028 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 872,000,000		842,000,000
Debt Instrument, Interest Rate, Stated Percentage	2.25%	2.25%
2.70% notes due 2029 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 750,000,000		750,000,000
Debt Instrument, Interest Rate, Stated Percentage	2.70%	2.70%
1.95% notes due 2030 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,000,000,000		0
Debt Instrument, Interest Rate, Stated Percentage	1.95%	1.95%
0.750% Euro notes due 2032 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 582,000,000	€ 500	0
Debt Instrument, Interest Rate, Stated Percentage	0.75%	0.75%
5.70% notes due 2036 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 441,000,000		441,000,000
Debt Instrument, Interest Rate, Stated Percentage	5.70%	5.70%
5.70% notes due 2037 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 462,000,000		462,000,000
Debt Instrument, Interest Rate, Stated Percentage	5.70%	5.70%
5.375% notes due 2041 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 417,000,000		417,000,000
Debt Instrument, Interest Rate, Stated Percentage	5.375%	5.375%
3.812% notes due 2047 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 445,000,000		445,000,000
Debt Instrument, Interest Rate, Stated Percentage	3.812%	3.812%
2.80% notes due 2050 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 750,000,000		0
Debt Instrument, Interest Rate, Stated Percentage	2.80%	2.80%
Industrial development bond obligations, floating rate maturing at various dates through 2037 [Member]
Debt Instrument [Line Items]
Industrial development bond	$ 22,000,000		22,000,000
6.625% debentures due 2028 [Member]
Debt Instrument [Line Items]
Junior Subordinated Notes	$ 201,000,000		201,000,000
Debt Instrument, Interest Rate, Stated Percentage	6.625%	6.625%
9.065% debentures due 2033 [Member]
Debt Instrument [Line Items]
Junior Subordinated Notes	$ 51,000,000		51,000,000
Debt Instrument, Interest Rate, Stated Percentage	9.065%	9.065%
Other Including Capitalized Leases And Debt Issuance Costs 8.0% Weighted Average Maturing At Various Dates Through 2025
Debt Instrument [Line Items]
Other long term debt	$ 343,000,000		$ 278,000,000
Debt, Weighted Average Interest Rate	8.00%	8.00%
The 2020 Euro Notes [Member]
Debt Instrument [Line Items]
Gross proceeds	$ 1,100,000,000
Discount and closing costs related to the offering	9,000,000
The 2020 Notes [Member]
Debt Instrument [Line Items]
Gross proceeds	3,000,000,000.0
Discount and closing costs related to the offering	27,000,000
The 2022 Callable Notes [Member]
Debt Instrument [Line Items]
Gross proceeds	3,000,000,000.0
Discount and closing costs related to the offering	10,000,000
Syndicate Of Banks [Member] \| $1.5B 364-Day Credit Agreement [Member]
Line of Credit Facility [Line Items]
Line of credit facility, current borrowing capacity	1,500,000,000
Line of credit facility, remaining borrowing capacity	1,500,000,000
Syndicate Of Banks [Member] \| Term Loan Agreement [Member]
Line of Credit Facility [Line Items]
Line of credit facility, borrowing capacity of prior agreement	6,000,000,000.0
Amount of permanent reduction of the Unused Commitments	$ 3,000,000,000.0

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share [Abstract]
Net income attributable to Honeywell	$ 758	$ 1,624	$ 3,420	$ 4,581
Weighted average shares outstanding	702,600,000	717,600,000	704,800,000	723,500,000
Earnings per share of common stock - basic (in dollars per share)	$ 1.08	$ 2.26	$ 4.85	$ 6.33
Assuming dilution
Net income attributable to Honeywell	$ 758	$ 1,624	$ 3,420	$ 4,581
Average shares
Weighted average shares outstanding	702,600,000	717,600,000	704,800,000	723,500,000
Dilutive securities issuable - stock plans	7,000,000.0	9,100,000	6,800,000	9,300,000
Total weighted average shares outstanding	709,600,000	726,700,000	711,600,000	732,800,000
Earnings per share of common stock - assuming dilution (in dollars per share)	$ 1.07	$ 2.23	$ 4.81	$ 6.25
Earnings Per Share Paragraph Details [Abstract]
Stock options excluded from diluted computations	7,100,000	2,900,000	6,400,000	3,200,000
Shares outstanding	701,700,000	714,500,000	701,700,000	714,500,000
Common Stock Shares Issued	957,600,000	957,600,000	957,600,000	957,600,000

REPOSITIONING AND OTHER CHARGES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	$ 124	$ 86	$ 449	$ 228
Asbestos related litigation charges, net of insurance and reimbursements	13	9	33	26
Probable and reasonably estimable environmental liabilities, net of reimbursements	6	6	20	59
Other	1	(5)	(16)	(7)
Total net repositioning and other charges	144	96	486	306
Severance
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	113	41	433	147
Asset impairments
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	5	15	11	26
Exit costs
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	17	33	47	62
Reserve adjustments
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	$ (11)	$ (3)	$ (42)	$ (7)

LEASES 2 (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Assets and Liabilities, Lessee [Abstract]
Other assets	$ 725	$ 673
Accrued liabilities	179	171
Other liabilities	597	534
Total operating lease liabilities	776	705
Property, plant and equipment	360	361
Accumulated depreciation	(171)	(152)
Property, plant and equipment - net	189	209
Current maturities of long-term debt	61	59
Long-term debt	135	156
Total financing lease liability	$ 196	$ 215

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Earnings per share basic


	Three Months Ended September 30,				Nine Months Ended September 30,
Basic	2020		2019		2020		2019
Net income attributable to Honeywell	$	758	$	1,624	$	3,420	$	4,581
Weighted average shares outstanding	702.6		717.6		704.8		723.5
Earnings per share of common stock	$	1.08	$	2.26	$	4.85	$	6.33

Earnings per share diluted


	Three Months Ended September 30,				Nine Months Ended September 30,
Assuming Dilution	2020		2019		2020		2019
Net income attributable to Honeywell	$	758	$	1,624	$	3,420	$	4,581
Average Shares
Weighted average shares outstanding	702.6		717.6		704.8		723.5
Dilutive securities issuable - stock plans	7.0		9.1		6.8		9.3
Total weighted average shares outstanding	709.6		726.7		711.6		732.8
Earnings per share of common stock	$	1.07	$	2.23	$	4.81	$	6.25

INVENTORIES 2 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
INVENTORIES 2 (Details) - USD ($) $ in Millions	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of products and services sold	$ 5,383	$ 6,038	$ 16,193	$ 18,011
Products [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of products and services sold	$ 4,315	$ 4,775	$ 12,852	$ 14,244
Change In Accounting Principle Other [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Percentage of LIFO Inventory	6.00%		6.00%
Change In Accounting Principle Other [Member] \| Products [Member] \| Performance Materials and Technologies
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of products and services sold	$ (7)

INVENTORIES (Tables)

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventories


	September 30, 2020		December 31, 2019
Raw materials	$	1,081	$	1,056
Work in process	850		817
Finished products	2,774		2,593
	4,705		4,466
Reduction to LIFO cost basis	—		(45)
	$	4,705	$	4,421

COMMITMENTS AND CONTINGENCIES 2 (Details)	9 Months Ended
COMMITMENTS AND CONTINGENCIES 2 (Details)	Sep. 30, 2020 USD ($)
Asbestos Related Liabilities [Member]
Loss Contingency Accrual [Roll Forward]
Asbestos Related Liabilities, Beginning of Period	$ 2,357,000,000
Accrual for update to estimated liability	59,000,000
Asbestos related liability payments	(210,000,000)
Asbestos Related Liabilities, End of Period	2,206,000,000
Asbestos Related Liabilities Insurance Recoveries [Line Items]
Insurance Recoveries, beginning of period	434,000,000
Probable insurance recoveries related to estimated liability	0
Insurance receipts for asbestos related liabilities	(17,000,000)
Insurance receivables settlements	(1,000,000)
Insurance recoveries, end of period	416,000,000
Bendix Asbestos Loss Contingency Liability [Member]
Loss Contingency Accrual [Roll Forward]
Asbestos Related Liabilities, Beginning of Period	1,499,000,000
Accrual for update to estimated liability	45,000,000
Asbestos related liability payments	(143,000,000)
Asbestos Related Liabilities, End of Period	1,401,000,000
Asbestos Related Liabilities Insurance Recoveries [Line Items]
Insurance Recoveries, beginning of period	153,000,000
Probable insurance recoveries related to estimated liability	0
Insurance receipts for asbestos related liabilities	(10,000,000)
Insurance receivables settlements	0
Insurance recoveries, end of period	143,000,000
Narco Asbestos Loss Contingency Liability [Member]
Loss Contingency Accrual [Roll Forward]
Asbestos Related Liabilities, Beginning of Period	858,000,000
Accrual for update to estimated liability	14,000,000
Asbestos related liability payments	(67,000,000)
Asbestos Related Liabilities, End of Period	805,000,000
Asbestos Related Liabilities Insurance Recoveries [Line Items]
Insurance Recoveries, beginning of period	281,000,000
Probable insurance recoveries related to estimated liability	0
Insurance receipts for asbestos related liabilities	(7,000,000)
Insurance receivables settlements	(1,000,000)
Insurance recoveries, end of period	$ 273,000,000

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)

9 Months Ended

Sep. 30, 2020

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Changes in Accumulated Other Comprehensive Income by Component

Changes in Accumulated Other Comprehensive Income (Loss) by Component


	Foreign Exchange Translation Adjustment		Pension and Other Postretirement Benefits Adjustments		Changes in Fair Value of Cash Flow Hedges		Total
Balance at December 31, 2019	$	(2,566)	$	(675)	$	44	$	(3,197)
Other comprehensive income (loss) before reclassifications	(227)		—		50		(177)
Amounts reclassified from accumulated other comprehensive income	(10)		(60)		8		(62)
Net current period other comprehensive income (loss)	(237)		(60)		58		(239)
Balance at September 30, 2020	$	(2,803)	$	(735)	$	102	$	(3,436)


	Foreign Exchange Translation Adjustment		Pension and Other Postretirement Benefits Adjustments		Changes in Fair Value of Cash Flow Hedges		Total
Balance at December 31, 2018	$	(2,709)	$	(761)	$	33	$	(3,437)
Other comprehensive income (loss) before reclassifications	188		—		110		298
Amounts reclassified from accumulated other comprehensive income	(11)		(59)		(86)		(156)
Net current period other comprehensive income (loss)	177		(59)		24		142
Balance at September 30, 2019	$	(2,532)	$	(820)	$	57	$	(3,295)

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Tables)

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

See the following table and related discussions by operating segment for details.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Aerospace
Commercial Aviation Original Equipment	$	406	$	772	$	1,527	$	2,265
Commercial Aviation Aftermarket	774		1,452		2,807		4,234
Defense and Space	1,482		1,320		4,232		3,894
	2,662		3,544		8,566		10,393
Honeywell Building Technologies
Products	751		823		2,163		2,476
Building Solutions	554		592		1,600		1,778
	1,305		1,415		3,763		4,254
Performance Materials and Technologies
UOP	461		717		1,572		2,030
Process Solutions	1,135		1,283		3,379		3,818
Specialty Products	261		256		786		790
Fluorine Products	395		414		1,130		1,339
	2,252		2,670		6,867		7,977
Safety and Productivity Solutions
Safety and Retail	599		558		1,612		1,653
Productivity Solutions and Services	322		307		877		926
Warehouse and Workflow Solutions	445		383		1,457		1,361
Sensing & Internet-of-Things (IoT)	212		209		595		649
	1,578		1,457		4,541		4,589
Net sales	$	7,797	$	9,086	$	23,737	$	27,213

The disaggregation of the Company's revenue based off timing of recognition is as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Products, transferred point in time	61	%	62	%	61	%	61	%
Products, transferred over time	15		13		15		14
Net product sales	76		75		76		75
Services, transferred point in time	7		8		8		9
Services, transferred over time	17		17		16		16
Net service sales	24		25		24		25
Net sales	100	%	100	%	100	%	100	%

Contract with Customer Asset and Liability [Table Text Block]

The following table summarizes the Company's contract assets and liabilities balances:


	2020		2019
Contract assets - January 1	$	1,602	$	1,548
Contract assets - September 30	1,819		1,812
Change in contract assets - increase (decrease)	$	217	$	264

Contract liabilities - January 1	$	(3,501)	$	(3,378)
Contract liabilities - September 30	(3,666)		(3,188)
Change in contract liabilities - decrease (increase)	$	(165)	$	190

Net change	$	52	$	454

Revenue Remaining Performance Obligation Expected Timing of Satisfaction [Table Text Block]

The following table outlines the Company's remaining performance obligations disaggregated by segment:


	September 30, 2020
Aerospace	$	9,717
Honeywell Building Technologies	5,537
Performance Materials and Technologies	6,532
Safety and Productivity Solutions	3,858
	$	25,644

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 16. Commitments and Contingencies

Environmental Matters

Our environmental matters are described in Note 20 Commitments and Contingencies of Notes to Consolidated Financial Statements in our 2019 Annual Report on Form 10-K.

The following table summarizes information concerning our recorded liabilities for environmental costs:


December 31, 2019	$	709
Accruals for environmental matters deemed probable and reasonably estimable	127
Environmental liability payments	(166)
Other	(4)
September 30, 2020	$	666

Environmental liabilities are included in the following balance sheet accounts:


	September 30, 2020		December 31, 2019
Accrued liabilities	$	222	$	222
Other liabilities	444		487
	$	666	$	709

The Company does not currently possess sufficient information to reasonably estimate the amounts of environmental liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined although they could be material to our consolidated results of operations and operating cash flows in the periods recognized or paid. However, considering our past experience and existing reserves, the Company does not expect that environmental matters will have a material adverse effect on its consolidated financial position.

In conjunction with the Resideo Technologies, Inc. (Resideo) spin-off, the Company entered into an indemnification and reimbursement agreement with a Resideo subsidiary, pursuant to which Resideo’s subsidiary has an ongoing obligation to make cash payments to Honeywell in amounts equal to 90 percent of Honeywell’s annual net spending for environmental matters at certain sites as defined in the agreement. The amount payable to Honeywell in any given year is subject to a cap of $140 million, and the obligation will continue until the earlier of December 31, 2043, or December 31 of the third consecutive year during which the annual payment obligation is less than $25 million.

Reimbursements associated with this agreement are collected from Resideo quarterly and were $70 million in the nine months ended September 30, 2020. On July 28, 2020, the Company and Resideo agreed to a second amendment of the indemnification and reimbursement agreement to extend the payment due date to October 30, 2020 for the reimbursement amount of $35 million (originally due on April 30, 2020). The Company had previously agreed to extend the payment date for such amount to July 30, 2020. As the Company incurs costs for environmental matters deemed probable and reasonably estimable related to the sites covered by the indemnification and reimbursement agreement, a corresponding receivable from Resideo for 90 percent of such costs is also recorded. This receivable amount recorded in the nine months ended September 30, 2020 was $107 million. As of September 30, 2020, Other Current Assets and Other Assets include $140 million and $482 million, respectively for the short-term and long-term portion of the receivable amount due from Resideo under the indemnification and reimbursement agreement.

Asbestos Matters

Honeywell is named in asbestos related personal injury claims related to North American Refractories Company (NARCO), which was sold in 1986, and Bendix Friction Materials (Bendix) business, which was sold in 2014.

The following tables summarize information concerning NARCO and Bendix asbestos-related balances:


Asbestos-Related Liabilities
	Bendix		NARCO		Total
December 31, 2019	$	1,499	$	858	$	2,357
Accrual for update to estimated liability	45		14		59
Asbestos related liability payments	(143)		(67)		(210)
September 30, 2020	$	1,401	$	805	$	2,206


Insurance Recoveries for Asbestos-Related Liabilities
	Bendix		NARCO		Total
December 31, 2019	$	153	$	281	$	434
Probable insurance recoveries related to estimated liability	—		—		—
Insurance receipts for asbestos-related liabilities	(10)		(7)		(17)
Insurance receivables settlements	—		(1)		(1)
September 30, 2020	$	143	$	273	$	416

NARCO and Bendix asbestos-related balances are included in the following balance sheet accounts:


	September 30, 2020		December 31, 2019
Other current assets	$	42	$	42
Insurance recoveries for asbestos-related liabilities	374		392
	$	416	$	434
Accrued liabilities	$	361	$	361
Asbestos-related liabilities	1,845		1,996
	$	2,206	$	2,357

NARCO Products – Honeywell’s predecessor, Allied Corporation owned NARCO from 1979 to 1986. When the NARCO business was sold, Honeywell’s predecessor entered into a cross-indemnity agreement with NARCO which included an obligation to indemnify the purchaser for asbestos claims. Such claims arise primarily from alleged occupational exposure to asbestos-containing refractory brick and mortar for high-temperature applications. NARCO ceased manufacturing these products in 1980, and the first asbestos claims were filed in the tort system against NARCO in 1983. Claims filings and related costs increased dramatically in the late 1990s through 2001, which led to NARCO filing for bankruptcy in January 2002. Once NARCO filed for bankruptcy, all then current and future NARCO asbestos claims were stayed against both NARCO and Honeywell pending the reorganization of NARCO.

Following the bankruptcy filing, in December 2002 Honeywell recorded a total NARCO asbestos liability of $3.2 billion, which was comprised of three components: (i) the estimated liability to settle pre-bankruptcy petition NARCO claims and certain post-petition settlements ($2.2 billion, referred to as “Pre-bankruptcy NARCO Liability”), (ii) the estimated liability related to then unasserted NARCO claims for the period 2004 through 2018 ($950 million, referred to as “NARCO Trust Liability”), and (iii) other NARCO bankruptcy-related obligations totaling $73 million.

When the NARCO Trust Liability of $950 million was established in 2002, the methodology for estimating the potential liability was based primarily on: (a) epidemiological projections of the future incidence of disease for the period 2004 through 2018, a fifteen-year period; (b) historical claims rates in the tort system for the five-year period prior to the bankruptcy filing date; and (c) anticipated NARCO Trust payment values set forth in the then current draft of the NARCO Trust Distribution Procedures. The methodology required estimating, by disease, three critical inputs: (i) likely number of claims to be asserted against the NARCO Trust in the future, (ii) percentage of those claims likely to receive payment, and (iii) payment values. The Company utilized outside asbestos liability valuation specialists to support its preparation of the NARCO Trust Liability estimate, which was based on a commonly accepted methodology used by numerous bankruptcy courts addressing 524(g) trusts.

In 2002, when the Company first established its initial liability, NARCO asbestos claims resolution shifted from the tort system to an anticipated NARCO Trust framework, where claims would be processed in accordance with established NARCO Trust Distribution Procedures, including strict medical and exposure criteria for a plaintiff to receive compensation. The Company believed at the time that the NARCO Trust’s claims filing and resolution experience after the NARCO Trust became operational would be significantly different from pre-bankruptcy tort system experience in light of these more rigorous claims processing requirements in the NARCO Trust Distribution Procedures and Honeywell’s active oversight of claims processing and approval. Given these anticipated differences, the Company believed that a 15-year time period was the appropriate horizon for establishing a probable and reasonably estimable liability for then unasserted NARCO claims as it represented its best estimate of the time period it would take for the NARCO Trust to be approved by the Bankruptcy Court, become fully operational and generate sufficiently reliable claims data (i.e., a data set which is statistically representative) to enable the Company to update its NARCO Trust Liability.

The NARCO Trust Distribution Procedures were finalized in 2006, and the Company updated its NARCO Trust Liability to reflect the final terms and payment values. The original 15-year period (from 2004 through 2018) for unasserted claims did not change as asbestos claims filings continued to be stayed against both Honeywell and NARCO. The 2006 update resulted in a range of the estimated liability for unasserted claims of $743 million to $961 million, and the Company believed that no amount within this range was a better estimate than any other amount. In accordance with ASC 450 – Contingencies (ASC 450), the Company recorded the low end of the range of $743 million (the "2006 NARCO Trust Liability Estimate") which resulted in a reduction of $207 million in our NARCO Trust Liability.

NARCO emerged from bankruptcy on April 30, 2013, at which time a federally authorized 524(g) trust was established for the evaluation and resolution of all existing and future NARCO asbestos claims. Both Honeywell and NARCO are protected by a permanent channeling injunction barring all present and future individual actions in state or federal courts and requiring all asbestos-related claims based on exposure to NARCO asbestos-containing products to be made against the NARCO Trust.

The NARCO Trust Agreement and the NARCO Trust Distribution Procedures are the principal documents setting forth the structure of the NARCO Trust. These documents establish Honeywell’s evergreen funding obligations. Honeywell is obligated to fund NARCO asbestos claims submitted to the NARCO Trust which qualify for payment under the Trust Distribution Procedures (Annual Contribution Claims), subject to an annual cap of $145 million. However, the initial $100 million of claims processed through the NARCO Trust (the "Initial Claims Amount") will not count against the annual cap and any unused portion of the Initial Claims Amount will roll over to subsequent years until fully utilized. These documents also establish the material operating rules for the NARCO Trust, including Honeywell audit rights and the criteria claimants must meet to have a valid claim paid. These claims payment criteria include providing the NARCO Trust with adequate medical evidence of the claimant’s asbestos-related condition and credible evidence of exposure to a specific NARCO asbestos-containing product. Further, the NARCO Trust is eligible to receive cash dividends from Harbison-Walker International Inc (HWI), the reorganized and renamed entity that emerged, fully operational, from the NARCO bankruptcy. The NARCO Trust is required to use any funding received from HWI to pay Annual Contribution Claims until those funds are exhausted. It is only at this point that Honeywell’s funding obligation to the Trust is triggered. Thus, there is an unrelated primary source for funding that affects Honeywell’s funding of the NARCO Trust Liability.

Once operational, the NARCO Trust began to receive, process and pay claims that had been previously stayed pending the Trust becoming operational. As the NARCO Trust began to pay claims in 2014, the Company began to assert our on-going audit rights to review and monitor the claims processor’s adherence to the established requirements of the NARCO Trust Distribution Procedures. While doing so, the Company identified several issues with the way the Trust was implementing the NARCO Trust Distribution Procedures. In 2015, Honeywell filed suit against the NARCO Trust in Bankruptcy Court alleging breach of certain provisions of the NARCO Trust Agreement and NARCO Trust Distribution Procedures. The parties agreed to dismiss the proceeding without prejudice pursuant to an 18-month Standstill Agreement, which expired in October 2017. Notwithstanding its expiration, claims processing continues, and Honeywell continues to negotiate and attempt to resolve remaining disputed issues (that is, instances where Honeywell believes the NARCO Trust is not processing claims in accordance with established NARCO Trust Distribution Procedures). Honeywell reserves the right to seek judicial intervention should negotiations fail.

After the NARCO Trust became effective in 2013, the $743 million NARCO Trust Liability was then comprised of:

(i)liability for unasserted claims; and

(ii)liability for claims asserted after the NARCO Trust became operational but not yet paid.

Although we know the number of claims filed with the NARCO Trust each year, the Company is not able to determine at this time the portion of the NARCO Trust Liability which represents asserted versus unasserted claims due to the lack of sufficiently reliable claims data because of the claims processing issues described previously.

Honeywell continues to maintain the 2006 NARCO Trust Liability Estimate (the $743 million accrual less payments made by Honeywell to the NARCO Trust for Annual Contribution Claims since the beginning of the fourth quarter of 2019), as there has not been sufficiently reliable claims data history to enable the Company to update that liability.

As of December 31, 2019, all cash dividends paid to the NARCO Trust by HWI had been used to pay Annual Contribution Claims. In the nine months ended September 30, 2020, Honeywell funded $54 million to the NARCO Trust for the payment of Annual Contribution Claims.

As of September 30, 2020, the Company's total NARCO asbestos liability of $805 million reflects Pre-bankruptcy NARCO Liability of $145 million and NARCO Trust Liability of $660 million (the $743 million accrual for the 2006 NARCO Trust Liability Estimate was reduced by $83 million of payments by Honeywell to the NARCO Trust for Annual Contribution Claims since HWI cash dividend funding was fully exhausted in the fourth quarter of 2019 and there have been no further dividends from HWI). Through September 30, 2020, Pre-bankruptcy NARCO Liability has been reduced by approximately $2 billion since first established in 2002, largely related to settlement payments. The remaining Pre-bankruptcy NARCO Liability principally represents estimated amounts owed pursuant to settlement agreements reached during the pendency of the NARCO bankruptcy proceedings that provide for the right to submit claims to the NARCO Trust subject to qualification under the terms of the settlement agreements and Trust Distribution Procedures. The other NARCO bankruptcy related obligations were paid in 2013 and no further liability is recorded.

Honeywell continues to evaluate the appropriateness of the 2006 NARCO Trust Liability Estimate. Despite becoming effective in 2013, the NARCO Trust has experienced delays in becoming fully operational. Violations of the Trust Distribution Procedures and the resulting disputes and challenges, a standstill pending dispute resolution, and limited claims payments, have all contributed to the lack of sufficient normalized data based on actual claims processing experience in the Trust since it became operational. As a result, Honeywell has not been able to further update the NARCO Trust Liability aside from deducting Honeywell payments to the NARCO Trust for Annual Contribution Claims. The 2006 NARCO Trust Liability Estimate continues to be appropriate because of the unresolved pending claims in the Trust, some portion of which will result in payouts in the future, and because new claims continue to be filed with the NARCO Trust. When sufficiently reliable claims data exists, the Company will update its estimate of the NARCO Trust Liability and it is possible that a material change may need to be recognized.

Our insurance receivable of $273 million as of September 30, 2020, corresponding to the estimated liability for asserted and unasserted NARCO asbestos claims, reflects coverage which reimburses Honeywell for portions of NARCO-related indemnity and defense costs and is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Honeywell conducts analyses to estimate the probable amount of insurance that is recoverable for asbestos claims. While the substantial majority of our insurance carriers are solvent, some of our individual carriers are insolvent, which has been considered in our analysis of probable recoveries. Honeywell made judgments concerning insurance coverage that Honeywell believes are reasonable and consistent with Honeywell's historical dealings and Honeywell's knowledge of any pertinent solvency issues surrounding insurers.

Bendix Products—Bendix manufactured automotive brake linings that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements. The following tables present information regarding Bendix-related asbestos claims activity:


	Nine Months Ended September 30,	Years Ended December 31,
Claims Activity	2020	2019	2018
Claims unresolved at the beginning of period	6,480	6,209	6,280
Claims filed	1,621	2,659	2,430
Claims resolved	(1,680)	(2,388)	(2,501)
Claims unresolved at the end of period	6,421	6,480	6,209


Disease Distribution of Unresolved Claims	September 30,	December 31,
	2020	2019	2018
Mesothelioma and other cancer claims	3,404	3,399	2,949
Nonmalignant claims	3,017	3,081	3,260
Total claims	6,421	6,480	6,209

Honeywell has experienced average resolution values per claim excluding legal costs as follows:


	Years Ended December 31,
	2019		2018		2017		2016		2015
	(in whole dollars)
Malignant claims	$	50,200	$	55,300	$	56,000	$	44,000	$	44,000
Nonmalignant claims	$	3,900	$	4,700	$	2,800	$	4,485	$	100

It is not possible to predict whether resolution values for Bendix-related asbestos claims will increase, decrease or stabilize in the future.

The Company's Consolidated Financial Statements reflect an estimated liability for resolution of asserted (claims filed as of the financial statement date) and unasserted Bendix-related asbestos claims and excludes the Company’s ongoing legal fees to defend such asbestos claims which will continue to be expensed as they are incurred. The Company has valued Bendix asserted and unasserted claims using average resolution values for the previous five years. The Company updates the resolution values used to estimate the cost of Bendix asserted and unasserted claims during the fourth quarter each year.

Honeywell reflects the inclusion of all years of epidemiological disease projection through 2059 when estimating the liability for unasserted Bendix-related asbestos claims. Such liability for unasserted Bendix-related asbestos claims is based on historic and anticipated claims filing experience and dismissal rates, disease classifications, and resolution values in the tort system for the previous five years.

The Company's insurance receivable corresponding to the liability for settlement of asserted and unasserted Bendix asbestos claims reflects coverage which is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Based on our ongoing analysis of the probable insurance recovery, insurance receivables are recorded in the financial statements simultaneous with the recording of the estimated liability for the underlying asbestos claims. This determination is based on the Company's analysis of the underlying insurance policies, the Company's historical experience with our insurers, the Company's ongoing review of the solvency of its insurers, judicial determinations relevant to our insurance programs, and the Company's consideration of the impacts of any settlements reached with its insurers.

On October 31, 2018, David Kanefsky, a Honeywell shareholder, filed a putative class action complaint in the U.S. District Court for the District of New Jersey alleging violations of the Securities Exchange Act of 1934 and Rule 10b-5 related to the prior accounting for Bendix asbestos claims. An Amended Complaint was filed on December 30, 2019, and on February 7, 2020, we filed a Motion to Dismiss. On May 18, 2020, the court denied our Motion to Dismiss. We believe the claims have no merit.

Garrett Matter

In conjunction with the Garrett spin-off, the Company entered into a binding indemnification and reimbursement agreement (“Garrett Indemnity”) with a Garrett subsidiary, pursuant to which Garrett’s subsidiary has an ongoing obligation to make cash payments to Honeywell in amounts equal to (i) 90% of Honeywell’s asbestos-related liability payments primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments, including the legal costs of defending and resolving such liabilities, less (ii) 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The amount payable to Honeywell in respect of such liabilities arising in any given year is subject to a cap of approximately Euro 150 million (equivalent to $175 million at the time the Garrett Indemnity was entered into). The obligation under the terms of the Garrett Indemnity continues until the earlier of December 31, 2048, or December 31 of the third consecutive year during which the annual obligation is less than the Euro equivalent, at the fixed exchange rate at the time the indemnification and reimbursement agreement was entered into, of $25 million.

Prior to the Garrett filing described below, on June 12, 2020, the Company and Garrett entered into an amendment of the Garrett Indemnity in connection with Garrett’s amendment of its 2018 credit agreement. These amendments provided Garrett with temporary financial covenant relief with respect to the total leverage and interest coverage ratios, for a period that could extend to as late as June 30, 2022. Garrett’s payments to the Company under the Garrett Indemnity were deferred to the extent Garrett is (or to the extent such payments would cause Garrett to be) out of compliance with the original financial covenants and resume to the extent Garrett is in compliance with such original financial covenants. Any deferred amounts were to be paid to the extent Garrett was in compliance with such original financial covenants and had available capacity to make such payments pursuant to the terms of the indemnification and reimbursement agreement and its current credit agreement.

The receivable amount recorded in connection with the Garrett Indemnity in the nine months ended September 30, 2020 was $38 million. Amounts associated with the Garrett Indemnity are scheduled under the agreement to be collected from Garrett quarterly, and because of the extension referenced above and below, such amounts were $36 million in the nine months ended September 30, 2020.

In conjunction with the spin-off, Honeywell also entered into a binding tax matters agreement with Garrett and a Garrett subsidiary (the “Tax Matters Agreement”). The Tax Matters Agreement generally provides that Garrett is responsible and must indemnify Honeywell for all ordinary operating taxes, including income taxes, sales taxes, value-added taxes ("VAT") and payroll taxes, relating to Garrett for all periods, including periods prior to the spin-off, to the extent not paid prior to the spin-off date. In addition, among other items, as a result of the mandatory transition tax imposed by the Tax Cuts and Jobs Act, Garrett is required to make payments to Honeywell in the amount representing the net tax liability of Honeywell under the mandatory transition tax attributable to Garrett.

As of September 30, 2020, the Company’s receivables prior to the adjustments described herein from Garrett and/or certain of its subsidiaries were collectively as follows:


	September 30, 2020
Garrett Indemnification and Reimbursement	$	1,121
Tax Matters Agreement	273
Other Receivables, net	13
Total Reimbursement Receivables	$	1,407

Garrett Litigation and Bankruptcy Proceedings

On December 2, 2019, Garrett Motion Inc. and Garrett ASASCO Inc. filed a Summons with Notice and commenced a lawsuit in the Commercial Division of the Supreme Court of the State of New York, County of New York (the “State Court”), seeking to invalidate the Garrett Indemnity. Garrett seeks damages and a declaratory judgment based on various claims set forth in the Summons with Notice. On January 15, 2020, Garrett filed its complaint in the action, which asserted the same claims, and on March 5, 2020, we filed a Motion to Dismiss. To date, Garrett has not filed a response to the Motion to Dismiss. On June 12, 2020, given the challenges of operating in the COVID-19 environment, Honeywell and Garrett entered into a litigation status agreement pursuant to which (i) the parties agreed to make good faith efforts to limit near-term litigation spend on this matter, and (ii) the Company agreed to extend both the $2 million payment owed by Garrett to the Company on May 1, 2020 under the Garrett Indemnity and the $18 million payment owed by Garrett to the Company on April 1, 2020 under the Tax Matters Agreement until December 31, 2020 (which amounts, as previously disclosed, had been deferred to May 31, 2020). On July 17, 2020, the Company received a notice from Garrett asserting that Honeywell has caused material breaches of the Tax Matters Agreement and that the Tax Matters Agreement is unenforceable. On September 23, 2020, Garrett removed the existing State Court litigation against Honeywell to the Bankruptcy Court (as defined below). Honeywell moved to dismiss all of Garrett’s claims on October 13, 2020. Honeywell’s motion to dismiss is currently set for a hearing on November 18, 2020, subject to further direction from the Bankruptcy Court. Honeywell strongly believes that Garrett's allegations have no merit, nor are they material to Honeywell. We believe we have fully complied with our obligations under the indemnification and reimbursement agreement and the Tax Matters Agreement and that both agreements are valid and enforceable.

On September 20, 2020, Garrett and 36 of its affiliates filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). Based on its bankruptcy filings, Garrett is proposing to sell its business while in bankruptcy, and Garrett entered into a Share and Asset Purchase Agreement, dated as of September 20, 2020 (the “Proposed Stalking Horse Bid”), with KPS Capital Partners, LP (“KPS”) and filed proposed bidding procedures for an auction and other procedures related to the proposed sale. As most recently amended, the Proposed Stalking Horse Bid contemplates a proposed purchase of Garrett’s business for $2.6 billion and includes as part of the sale certain claims and causes of action against Honeywell and others arising out of the spin-off, with details related to this aspect of its proposed sale structure to be forthcoming. Garrett also entered into a restructuring support agreement (“RSA”) with holders of approximately 61% of its outstanding senior secured debt which contemplates that Garrett will file and seek approval of a restructuring plan that implements the sale of Garrett’s business, pays Garrett’s secured creditors in full and pays at least 90% of Garrett's unsecured notes obligations from the cash from the sale, provides Garrett’s current stockholders an opportunity to co-invest up to $350 million in the purchase of common stock of a new company organized by KPS to purchase Garrett’s business on same terms as KPS, and includes as part of the sale certain claims and causes of action against Honeywell and others arising out of the spin-off, with details related to this aspect of its proposed sale structure to be forthcoming. On October 23, 2020, the Bankruptcy Court approved “stalking horse” bidding protections for KPS, including a $63 million termination fee and expense reimbursement (subject to a limit of $21 million). The Proposed Stalking Horse Bid and restructuring plan remain subject to Bankruptcy Court approval. KPS’s purchase of Garrett's business remains subject to competing bids and Bankruptcy Court approval, as well as customary regulatory approvals and other customary conditions. Garrett’s operations are expected to proceed, without interruption, during the bankruptcy proceedings.

In October 2020, Honeywell signed a coordination agreement with Oaktree Capital Management, L.P. ("Oaktree") and Centerbridge Partners, L.P. ("Centerbridge"), which since has also been signed by equity holders representing approximately 50% of Garrett’s outstanding common stock. The coordination agreement supports a proposed plan of reorganization (the “Plan”) that would allow Honeywell to recover over time a significant portion of the receivable amounts owed to Honeywell (the “Alternative Proposal”). As currently contemplated, the Alternative Proposal provides that, if the Plan is approved, Honeywell would receive an initial payment of $275 million in cash and new series B preferred stock of reorganized Garrett. In total, the Alternative Proposal would provide for cash payments totaling $1.45 billion comprising the initial cash payment of $275 million and $1.175 billion paid over a twelve-year period ending December 31, 2034 (unless a discounted amount is paid earlier pursuant to certain put, call or acceleration provisions). These cash payments would be paid in full and final satisfaction of Garrett’s obligations to Honeywell under the indemnification and reimbursement agreement and tax matters agreement. Under the Alternative Proposal, both agreements would be terminated in connection with Bankruptcy Court confirmation of the Alternative Proposal. In addition, under the Alternative Proposal, Garrett’s secured creditors and unsecured notes obligations would be paid in full, and equity would be reinstated. The Alternative Proposal remains subject to various conditions and milestones, as well as Bankruptcy Court approval, and Garrett has not accepted the Alternative Proposal to date. There can be no assurance that a plan of reorganization incorporating the terms contemplated by the Alternative Proposal will be approved and confirmed by the Bankruptcy Court.

Garrett is early in the bankruptcy proceedings and the ultimate outcome of such proceedings is uncertain. We regularly review the aggregate carrying value of the receivable amounts due in connection with the Garrett Indemnity and the Tax Matters Agreement. Following Garrett’s bankruptcy filing, Honeywell's review has taken into account, among other things, the potential enterprise value of the Garrett business based on publicly available information, Garrett’s implied enterprise value under the Alternative Proposal (which supports our independent assessment), the possibility that there will be additional bids and/or other plan proposals that Honeywell believes should reflect the enterprise value of Garrett’s business, and the significant uncertainties associated with the potential outcomes of the Garrett bankruptcy proceedings. Based on such review, we currently believe that we will be able to recover a significant portion, but potentially not all, of the receivable amounts owed to us under the agreements with Garrett. As such, and based on the assumption that the Bankruptcy Court will approve a plan that reflects an enterprise value for Garrett that meets or exceeds Honeywell's best estimate, Honeywell has recorded an adjustment of $350 million to lower the aggregate carrying balance of the receivable amounts due in connection with the Garrett Indemnity and the Tax Matters Agreement. Honeywell recorded a corresponding, non-cash charge in our statement of operations in the third quarter of 2020 in the amount of $350 million. This amount represents the difference between the approximately $1.4 billion carrying value of the undiscounted receivables owed to Honeywell by Garrett under these agreements and the present value of amounts owed to us over the full term of these existing agreements.

The ultimate outcome of the bankruptcy process is uncertain. Depending on the transaction and/or plan of reorganization ultimately approved and confirmed by the Bankruptcy Court, the amount collected could be more or less than such reduced amount of the remaining receivable amounts recorded in our financial statements. There are currently two competing proposals, the Proposed Stalking Horse Bid and the Alternative Proposal (the "Competing Proposals") which both remain subject to modification, and it is possible that there will be additional bids and alternative proposals for plans of reorganization for Garrett. If either of the Competing Proposals is accepted and approved by the Bankruptcy Court in its current form, then there would be an additional write-down of the remaining receivables due from Garrett, with a corresponding charge to our statement of operations in the same amount. In the case of the current Proposed Stalking Horse Bid, such additional adjustment would be a significant portion of the remaining receivables due from Garrett. In the case of the Alternative Proposal, we would not expect such additional adjustment to be material. There can be no assurance that recording an additional adjustment (positive or negative) against the remaining receivable amounts in whole or in part (together with a related statement of operations charge) will not be necessary in a future period or periods. The ultimate outcome of the bankruptcy process is uncertain. Depending on the transaction and/or plan of reorganization ultimately approved and confirmed by the Bankruptcy Court, the amount collected could be more or less than such reduced amount of the remaining receivable amounts recorded in our financial statements. Honeywell will continue to monitor the Bankruptcy Court proceedings in order to appropriately assess and enforce our rights in this matter. Honeywell intends to vigorously defend its rights to collect amounts due under the Garrett Indemnity and Tax Matters Agreement with Garrett.

Other Matters

The Company is subject to a number of other lawsuits, investigations and disputes (some of which involve substantial amounts claimed) arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurrence and reasonably estimable. We continually assess the likelihood of adverse judgments of outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. Included in these other matters are the following:

Honeywell v. United Auto Workers (UAW) et. al—In September 2011, the UAW and certain Honeywell retirees (Plaintiffs) filed a suit in the Eastern District of Michigan (the District Court) alleging that a series of Master Collective Bargaining Agreements (MCBAs) between Honeywell and the UAW provided the retirees with rights to lifetime, vested healthcare benefits that could never be changed or reduced. Plaintiffs alleged that Honeywell had violated those vested rights by implementing express limitations (CAPS) on the amount Honeywell contributed toward healthcare coverage for the retirees. Honeywell subsequently answered the UAW’s complaint and asserted counterclaims, including for breach of implied warranty.

Between 2014 and 2015, Honeywell began enforcing the CAPS against former employees. In response, the UAW and certain of the Plaintiffs filed a motion seeking a ruling that the MCBAs do not limit Honeywell’s obligation to contribute to healthcare coverage for those retirees.

On March 29, 2018, the District Court issued its opinion resolving all pending summary judgment motions, except for Honeywell’s counterclaim for breach of implied warranty, which has since been dismissed without prejudice.

In the opinion, the District Court held that the MCBAs do not promise retirees vested, lifetime benefits that survive expiration of the MCBAs. Based on this ruling, Honeywell terminated the retirees healthcare coverage benefits altogether as of July 31, 2018. In response, the UAW filed a motion to enjoin Honeywell from completely terminating coverage as of July 31, 2018, arguing that the CAPS themselves are vested and that Honeywell must continue to provide retiree medical benefits at the capped level. On July 28, 2018, the District Court denied the UAW’s motion and entered a final judgment consistent with its March 2018 ruling. The UAW appealed this decision to the Sixth Circuit Court of Appeals.

In the March 2018 opinion, the District Court also held that Honeywell is obligated under the MCBAs to pay the “full premium” for retiree healthcare rather than the capped amount. Based on this ruling, Honeywell would be required to pay monetary damages to retirees for any past years in which Honeywell paid less than the “full premium” of their healthcare coverage. Such damages would be limited, depending on the retiree group, to a two to three-year period ending when the 2017 MCBA expired, and Honeywell would have no ongoing obligation to continue funding healthcare coverage for subsequent periods. Honeywell appealed the District Court’s ruling on this “full premium” damages issue.

On April 3, 2020, the Sixth Circuit Court of Appeals issued an opinion ruling for Honeywell in all respects. The Court of Appeals affirmed the District Court's ruling that the MCBAs do not promise retirees vested, lifetime benefits that survive expiration of the MCBAs. In addition, the Court of Appeals reversed the District Court's ruling that Honeywell was obligated under the MCBAs to pay the "full premium" for retiree healthcare, rather than the capped amount. As a result of these rulings, Honeywell is not required to pay any monetary damages to the Plaintiffs.

Plaintiffs sought rehearing en banc from the Sixth Circuit Court of Appeals, which petition was denied. Plaintiffs failed to timely appeal the Sixth Circuit's ruling to the Supreme Court of the United States. Accordingly, as of October 8, 2020, the case has now been fully resolved.

Petrobras and Unaoil—We are cooperating with certain investigations by the U.S. Department of Justice (DOJ), the SEC and Brazilian authorities relating to our use of third parties who previously worked for our UOP business in Brazil in relation to Petróleo Brasileiro S.A. (Petrobras). The investigations are focused on compliance with the U.S. Foreign Corrupt Practices Act and similar Brazilian laws, and involve, among other things, document production and interviews with former and current management and employees. The DOJ and the SEC are also examining a matter involving a foreign subsidiary’s prior engagement of Unaoil S.A.M. in Algeria. We are cooperating with the authorities in each of the above matters. While we cannot predict the outcome of these matters, based on the facts currently known to us, we do not anticipate that these matters will have a material adverse effect on our financial condition, results of operations, or cash flows.

Given the uncertainty inherent in litigation and investigations (including the specific matters referenced above), we do not believe it is possible to develop estimates of reasonably possible loss in excess of current accruals for these matters (other than as specifically set forth above). Considering our past experience and existing accruals, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our consolidated financial position. Because most contingencies are resolved over long periods of time, potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause us to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on our results of operations or operating cash flows in the periods recognized or paid.

REPOSITIONING AND OTHER CHARGES (Tables)

9 Months Ended

Sep. 30, 2020

Restructuring and Related Activities [Abstract]

Repositioning and other charges

A summary of repositioning and other charges follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Severance	$	113	$	41	$	433	$	147
Asset impairments	5		15		11		26
Exit costs	17		33		47		62
Reserve adjustments	(11)		(3)		(42)		(7)
Total net repositioning charge	124		86		449		228
Asbestos related litigation charges, net of insurance and reimbursements	13		9		33		26
Probable and reasonably estimable environmental liabilities, net of reimbursements	6		6		20		59
Other	1		(5)		(16)		(7)
Total net repositioning and other charges	$	144	$	96	$	486	$	306

Pretax distribution of total net repositioning and other charges by income statement classification

The following table summarizes the pretax distribution of total net repositioning and other charges by classification:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Cost of products and services sold	$	91	$	75	$	286	$	204
Selling, general and administrative expenses	53		21		200		102

	$	144	$	96	$	486	$	306

Pretax Impact of Total Net Repositioning and Other Charges by Segment

The following table summarizes the pretax impact of total net repositioning and other charges by segment:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Aerospace	$	33	$	12	$	151	$	32
Honeywell Building Technologies	29		28		87		36
Performance Materials and Technologies	34		28		139		61
Safety and Productivity Solutions	15		6		32		54
Corporate	33		22		77		123
	$	144	$	96	$	486	$	306

Total Repositioning Reserves

The following table summarizes the status of the Company's total repositioning reserves:


	Severance Costs		Asset Impairments		Exit Costs		Total
December 31, 2019	$	555	$	—	$	96	$	651
Charges	433		11		47		491
Usage - cash	(343)		—		(56)		(399)
Usage - noncash	—		(11)		—		(11)
Foreign currency translation	9		—		—		9
Adjustments	(40)		—		(2)		(42)
September 30, 2020	$	614	$	—	$	85	$	699

CONSOLIDATED STATEMENT OF SHAREOWNERS EQUITY - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]
Balance at beginning of period at Dec. 31, 2018			$ 6,452,000,000	$ (19,771,000,000)	$ 33,978,000,000	$ (3,437,000,000)	$ 178,000,000
Issued for employee savings and option plans			242,000,000	$ 286,000,000
Stock Issued During Period Shares For Employee Savings And Option Plans				7,000,000.0
Stock-based compensation expense			112,000,000
Treasury Stock, Shares beginning balance at Dec. 31, 2018				(228,000,000.0)
Reacquired stock or repurchases of common stock				$ (3,650,000,000)
Reacquired stock or repurchases of common stock, shares				(22,100,000)
Treasury Stock, Shares ending balance at Sep. 30, 2019				(243,100,000)
Net income attributable to Honeywell	$ 4,581,000,000				4,581,000,000
Acquisitions, divestitures, and other							1,000,000
Dividends on common stock					(1,784,000,000)
Foreign exchange translation adjustment	177,000,000					177,000,000	(3,000,000)
Pension and other postretirement benefit adjustments	(59,000,000)					(59,000,000)
Changes in fair value of effective cash flow hedges	24,000,000					24,000,000
Net Income attributable to noncontrolling interest	$ 59,000,000						59,000,000
Dividends Paid							(38,000,000)
Cash dividends per share of common stock	$ 2.460
Balance at end of period at Sep. 30, 2019	$ 18,306,000,000	$ 958,000,000	6,806,000,000	$ (23,135,000,000)	36,775,000,000	(3,295,000,000)	197,000,000
Common Stock, Shares, Issued, Ending Balance at Sep. 30, 2019	957,600,000	957,600,000
Balance at beginning of period at Jun. 30, 2019			6,780,000,000	(22,156,000,000)	35,741,000,000	(3,453,000,000)	190,000,000
Issued for employee savings and option plans			(11,000,000)	$ 21,000,000
Stock Issued During Period Shares For Employee Savings And Option Plans				900,000
Stock-based compensation expense			37,000,000
Treasury Stock, Shares beginning balance at Jun. 30, 2019				(238,100,000)
Reacquired stock or repurchases of common stock				$ (1,000,000,000)
Reacquired stock or repurchases of common stock, shares				(5,900,000)
Treasury Stock, Shares ending balance at Sep. 30, 2019				(243,100,000)
Net income attributable to Honeywell	$ 1,624,000,000				1,624,000,000
Acquisitions, divestitures, and other							1,000,000
Dividends on common stock					(590,000,000)
Foreign exchange translation adjustment	163,000,000					163,000,000	(5,000,000)
Pension and other postretirement benefit adjustments	(20,000,000)					(20,000,000)
Changes in fair value of effective cash flow hedges	15,000,000					15,000,000
Net Income attributable to noncontrolling interest	$ 24,000,000						24,000,000
Dividends Paid							(13,000,000)
Cash dividends per share of common stock	$ 0.820
Balance at end of period at Sep. 30, 2019	$ 18,306,000,000	$ 958,000,000	6,806,000,000	$ (23,135,000,000)	36,775,000,000	(3,295,000,000)	197,000,000
Common Stock, Shares, Issued, Ending Balance at Sep. 30, 2019	957,600,000	957,600,000
Shares outstanding	714,500,000
Balance at beginning of period at Dec. 31, 2019	$ 18,706,000,000		6,876,000,000	(23,836,000,000)	37,693,000,000	(3,197,000,000)	212,000,000
Issued for employee savings and option plans			161,000,000	$ 179,000,000
Stock Issued During Period Shares For Employee Savings And Option Plans				3,700,000
Stock-based compensation expense			118,000,000
Treasury Stock, Shares beginning balance at Dec. 31, 2019				(246,500,000)
Reacquired stock or repurchases of common stock				$ (2,149,000,000)
Reacquired stock or repurchases of common stock, shares				(13,100,000)
Treasury Stock, Shares ending balance at Sep. 30, 2020				(255,900,000)
Net income attributable to Honeywell	3,420,000,000				3,420,000,000
Acquisitions, divestitures, and other							(6,000,000)
Dividends on common stock					(1,910,000,000)
Foreign exchange translation adjustment	(237,000,000)					(237,000,000)	2,000,000
Pension and other postretirement benefit adjustments	(60,000,000)					(60,000,000)
Changes in fair value of effective cash flow hedges	58,000,000					58,000,000
Net Income attributable to noncontrolling interest	$ 66,000,000						66,000,000
Dividends Paid							(35,000,000)
Cash dividends per share of common stock	$ 2.700
Balance at end of period at Sep. 30, 2020	$ 18,313,000,000	$ 958,000,000	7,155,000,000	$ (25,806,000,000)	39,203,000,000	(3,436,000,000)	239,000,000
Common Stock, Shares, Issued, Ending Balance at Sep. 30, 2020	957,600,000	957,600,000
Balance at beginning of period at Jun. 30, 2020			7,104,000,000	(25,685,000,000)	39,080,000,000	(3,310,000,000)	219,000,000
Issued for employee savings and option plans			11,000,000	$ 43,000,000
Stock Issued During Period Shares For Employee Savings And Option Plans				900,000
Stock-based compensation expense			40,000,000
Treasury Stock, Shares beginning balance at Jun. 30, 2020				(255,800,000)
Reacquired stock or repurchases of common stock				$ (164,000,000)
Reacquired stock or repurchases of common stock, shares				(1,000,000.0)
Treasury Stock, Shares ending balance at Sep. 30, 2020				(255,900,000)
Net income attributable to Honeywell	$ 758,000,000				758,000,000
Acquisitions, divestitures, and other							0
Dividends on common stock					(635,000,000)
Foreign exchange translation adjustment	(82,000,000)					(82,000,000)	6,000,000
Pension and other postretirement benefit adjustments	(20,000,000)					(20,000,000)
Changes in fair value of effective cash flow hedges	(24,000,000)					(24,000,000)
Net Income attributable to noncontrolling interest	$ 23,000,000						23,000,000
Dividends Paid							(9,000,000)
Cash dividends per share of common stock	$ 0.900
Balance at end of period at Sep. 30, 2020	$ 18,313,000,000	$ 958,000,000	$ 7,155,000,000	$ (25,806,000,000)	$ 39,203,000,000	$ (3,436,000,000)	$ 239,000,000
Common Stock, Shares, Issued, Ending Balance at Sep. 30, 2020	957,600,000	957,600,000
Shares outstanding	701,700,000

COMMITMENTS AND CONTINGENCIES 8 (Details) € in Millions, $ in Millions	9 Months Ended	10 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($)	Oct. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)	Sep. 30, 2020 EUR (€)
Garrett Indemnification And Reimbursement Receivables [Member]
Loss Contingencies [Line Items]
Reimbursement Receivables	$ 1,400
Resideo [Member] \| Environmental Liabilities [Member]
Loss Contingencies [Line Items]
Indemnification and reimbursement agreement annual cap	140
Indemnification and reimbursement agreement minimum amount	25
Reimbursements from indemnification and reimbursement agreement	70
Reimbursement receivable indemnification and reimbursement agreement	107
Indemnity and reimbursement receivable recorded In Other Current Assets	140
Indemnity and reimbursement receivable recorded In Other Assets	482
Resideo [Member] \| Environmental Liabilities [Member] \| Forecast [Member] \| Original Due Date April 30, 2020 [Member]
Loss Contingencies [Line Items]
Reimbursements from indemnification and reimbursement agreement		$ 35
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member]
Loss Contingencies [Line Items]
Indemnification and reimbursement agreement annual cap	175			€ 150
Indemnification and reimbursement agreement minimum amount	25
Reimbursements from indemnification and reimbursement agreement	36
Reimbursement receivable indemnification and reimbursement agreement	38
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member] \| Garrett Indemnification And Reimbursement [Member]
Loss Contingencies [Line Items]
Reimbursement Receivables	1,121
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member] \| Garrett Tax Matters Agreement [Member]
Loss Contingencies [Line Items]
Reimbursement Receivables	273
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member] \| Garrett Other Receivables [Member]
Loss Contingencies [Line Items]
Reimbursement Receivables	13
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member] \| Garrett Indemnification And Reimbursement Receivables [Member]
Loss Contingencies [Line Items]
Reimbursement Receivables	$ 1,407
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member] \| Forecast [Member] \| Original Due Date April 1, 2020 [Member] \| Garrett Tax Matters Agreement [Member]
Loss Contingencies [Line Items]
Reimbursement receivable indemnification and reimbursement agreement			$ 18
Garrett [Member] \| Bendix Asbestos Loss Contingency Liability [Member] \| Forecast [Member] \| Original Due Date May 1, 2020 [Member] \| Garrett Indemnification And Reimbursement [Member]
Loss Contingencies [Line Items]
Reimbursement receivable indemnification and reimbursement agreement			$ 2

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 781	$ 1,648	$ 3,486	$ 4,640
Other comprehensive income (loss), net of tax
Foreign exchange translation adjustment	(82)	163	(237)	177
Prior service (credit) cost recognized	(20)	(20)	(60)	(59)
Pension and other postretirement benefit adjustments	(20)	(20)	(60)	(59)
Cash flow hedges recognized in other comprehensive income (loss)	(54)	62	50	110
Less: Reclassification adjustment for gains (losses) included in net income	(30)	47	(8)	86
Changes in fair value of effective cash flow hedges	(24)	15	58	24
Other comprehensive income (loss), net of tax	(126)	158	(239)	142
Comprehensive income	655	1,806	3,247	4,782
Less: Comprehensive income attributable to the noncontrolling interest	29	19	68	56
Comprehensive income attributable to Honeywell	$ 626	$ 1,787	$ 3,179	$ 4,726

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

9 Months Ended

Sep. 30, 2020

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss)

Note 13. Accumulated Other Comprehensive Income (Loss)

Changes in Accumulated Other Comprehensive Income (Loss) by Component


	Foreign Exchange Translation Adjustment		Pension and Other Postretirement Benefits Adjustments		Changes in Fair Value of Cash Flow Hedges		Total
Balance at December 31, 2019	$	(2,566)	$	(675)	$	44	$	(3,197)
Other comprehensive income (loss) before reclassifications	(227)		—		50		(177)
Amounts reclassified from accumulated other comprehensive income	(10)		(60)		8		(62)
Net current period other comprehensive income (loss)	(237)		(60)		58		(239)
Balance at September 30, 2020	$	(2,803)	$	(735)	$	102	$	(3,436)


	Foreign Exchange Translation Adjustment		Pension and Other Postretirement Benefits Adjustments		Changes in Fair Value of Cash Flow Hedges		Total
Balance at December 31, 2018	$	(2,709)	$	(761)	$	33	$	(3,437)
Other comprehensive income (loss) before reclassifications	188		—		110		298
Amounts reclassified from accumulated other comprehensive income	(11)		(59)		(86)		(156)
Net current period other comprehensive income (loss)	177		(59)		24		142
Balance at September 30, 2019	$	(2,532)	$	(820)	$	57	$	(3,295)

INVENTORIES

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventories

Note 9. Inventories


	September 30, 2020		December 31, 2019
Raw materials	$	1,081	$	1,056
Work in process	850		817
Finished products	2,774		2,593
	4,705		4,466
Reduction to LIFO cost basis	—		(45)
	$	4,705	$	4,421

During the third quarter of 2020, the Company changed the method of valuing inventory from the last-in, first-out (LIFO) method to the first-in, first-out (FIFO) method for inventories within our Performance Materials and Technologies segment not previously valued using FIFO. The Company believes the FIFO method is preferable and better reflects the current value of inventory reported in the Consolidated Balance Sheet. The cumulative effect of this change in accounting principle was $7 million and was recorded as a reduction to Cost of products sold for the three months ended September 30, 2020. The inventories subject to this change totaled approximately 6 percent of consolidated inventories. This change was not material to the Consolidated Financial Statements, therefore prior periods were not adjusted retrospectively.

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Consolidated Statement of Operations
Net Sales	$ 7,797	$ 9,086	$ 23,737	$ 27,213
Costs, expenses and other
Cost of products and services sold	5,383	6,038	16,193	18,011
Selling, general and administrative expenses	1,103	1,296	3,524	4,046
Other (income) expense	62	(311)	(546)	(901)
Interest and other financial charges	101	96	264	266
Cost, operating and non-operating expenses	6,649	7,119	19,435	21,422
Income before taxes	1,148	1,967	4,302	5,791
Tax expense (benefit)	367	319	816	1,151
Net income	781	1,648	3,486	4,640
Less: Net income attributable to the noncontrolling interest	23	24	66	59
Net income attributable to Honeywell	$ 758	$ 1,624	$ 3,420	$ 4,581
Earnings per share of common stock - basic (in dollars per share)	$ 1.08	$ 2.26	$ 4.85	$ 6.33
Earnings per share of common stock - assuming dilution (in dollars per share)	$ 1.07	$ 2.23	$ 4.81	$ 6.25
Products [Member]
Consolidated Statement of Operations
Net Sales	$ 5,885	$ 6,793	$ 17,933	$ 20,496
Costs, expenses and other
Cost of products and services sold	4,315	4,775	12,852	14,244
Services [Member]
Consolidated Statement of Operations
Net Sales	1,912	2,293	5,804	6,717
Costs, expenses and other
Cost of products and services sold	$ 1,068	$ 1,263	$ 3,341	$ 3,767

LEASES (Details) - USD ($) $ in Millions	9 Months Ended
LEASES (Details) - USD ($) $ in Millions	Sep. 30, 2020	Sep. 30, 2019
Right Of Use Assets Obtained In Exchange For Lease [Abstract]
Operating leases	$ 155	$ 118
Finance leases	$ 24	$ 17

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES 4 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Gain (loss) on interest rate swap agreements	$ (13)	$ 55	$ 206	$ 118
Foreign exchange mark-to-market (ncome) expense	136	$ (182)	69	$ (231)
Cash collateral received	$ 323		$ 323

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS 3 (Details) $ in Millions	9 Months Ended
	Sep. 30, 2020 USD ($)
Revenue, Performance Obligation [Abstract]
Revenue Performance Obligation Description of Timing	Performance obligations recognized as of September 30, 2020 will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 54% and 46%, respectively.
Revenue Performance Obligation Description of Payment Terms	The timing of satisfaction of the Company's performance obligations does not significantly vary from the typical timing of payment. Typical payment terms of the Company's fixed-price over time contracts include progress payments based on specified events or milestones, or based on project progress. For some contracts we may be entitled to receive an advance payment.
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	$ 25,644
Within One Year [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, percentage	54.00%
Greater Than One Year [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, percentage	46.00%
Aerospace
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	$ 9,717
Honeywell Building Technologies
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	5,537
Performance Materials and Technologies
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	6,532
Safety and Productivity Solutions
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	$ 3,858

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Earnings Per Share

Note 6. Earnings Per Share


	Three Months Ended September 30,				Nine Months Ended September 30,
Basic	2020		2019		2020		2019
Net income attributable to Honeywell	$	758	$	1,624	$	3,420	$	4,581
Weighted average shares outstanding	702.6		717.6		704.8		723.5
Earnings per share of common stock	$	1.08	$	2.26	$	4.85	$	6.33


	Three Months Ended September 30,				Nine Months Ended September 30,
Assuming Dilution	2020		2019		2020		2019
Net income attributable to Honeywell	$	758	$	1,624	$	3,420	$	4,581
Average Shares
Weighted average shares outstanding	702.6		717.6		704.8		723.5
Dilutive securities issuable - stock plans	7.0		9.1		6.8		9.3
Total weighted average shares outstanding	709.6		726.7		711.6		732.8
Earnings per share of common stock	$	1.07	$	2.23	$	4.81	$	6.25

The diluted earnings per share calculations exclude the effect of stock options when the options’ exercise price exceed the average market price of the common shares during the period. For the three and nine months ended September 30, 2020, the weighted average number of stock options excluded from the computations were 7.1 million and 6.4 million. For the three and nine months ended September 30, 2019, the weighted average number of stock options excluded from the computations were 2.9 million and 3.2 million. These stock options were outstanding at the end of each of the respective periods.

As of September 30, 2020 and 2019, total shares outstanding were 701.7 million and 714.5 million and as of September 30, 2020 and 2019, total shares issued were 957.6 million.

REPOSITIONING AND OTHER CHARGES

9 Months Ended

Sep. 30, 2020

Restructuring and Related Activities [Abstract]

Repositioning and Other Charges

Note 3. Repositioning and Other Charges

A summary of repositioning and other charges follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Severance	$	113	$	41	$	433	$	147
Asset impairments	5		15		11		26
Exit costs	17		33		47		62
Reserve adjustments	(11)		(3)		(42)		(7)
Total net repositioning charge	124		86		449		228
Asbestos related litigation charges, net of insurance and reimbursements	13		9		33		26
Probable and reasonably estimable environmental liabilities, net of reimbursements	6		6		20		59
Other	1		(5)		(16)		(7)
Total net repositioning and other charges	$	144	$	96	$	486	$	306

The following table summarizes the pretax distribution of total net repositioning and other charges by classification:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Cost of products and services sold	$	91	$	75	$	286	$	204
Selling, general and administrative expenses	53		21		200		102

	$	144	$	96	$	486	$	306

The following table summarizes the pretax impact of total net repositioning and other charges by segment:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Aerospace	$	33	$	12	$	151	$	32
Honeywell Building Technologies	29		28		87		36
Performance Materials and Technologies	34		28		139		61
Safety and Productivity Solutions	15		6		32		54
Corporate	33		22		77		123
	$	144	$	96	$	486	$	306

In the three months ended September 30, 2020, the Company recognized gross repositioning charges totaling $135 million including severance costs of $113 million related to workforce reductions of 3,113 manufacturing and administrative positions across all of the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies. The workforce reductions primarily related to the Company aligning its cost structure with the current slowdown in demand for many of the Company's products and services due to the global recession.

In the three months ended September 30, 2019, the Company recognized gross repositioning charges totaling $89 million including severance costs of $41 million related to workforce reductions of 1,123 manufacturing and administrative positions across the Company's segments. The workforce reductions primarily related to cost savings actions taken in connection with our productivity and ongoing functional transformation initiatives. The repositioning charges included exit costs of $33 million primarily related to termination fees associated with the early cancellation of supply agreements for certain raw materials in Performance Materials and Technologies and Honeywell Building Technologies and current period exit costs incurred for previously approved repositioning projects.

In the nine months ended September 30, 2020, the Company recognized gross repositioning charges totaling $491 million including severance costs of $433 million related to workforce reductions of 13,042 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies. The workforce reductions primarily related to the Company aligning its cost structure with the current slowdown in demand for many of the Company's products and services due to the global recession, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charges included exit costs of $47 million primarily related to current period exit costs incurred for previously approved repositioning projects. Also, $42 million of previously established reserves, primarily for severance, were returned to income mainly as a result of higher attrition than anticipated in prior severance actions resulting in lower severance payments.

In the nine months ended September 30, 2019, the Company recognized gross repositioning charges totaling $235 million including severance costs of $147 million related to workforce reductions of 3,436 manufacturing and administrative positions across the Company's segments. The workforce reductions primarily related to cost savings actions taken in connection with the Company's productivity and functional transformation initiatives and to site transitions in Aerospace to more cost-effective locations. The repositioning charges included exit costs of $62 million primarily related to current period exit costs incurred for previously approved repositioning projects, termination fees associated with the early cancellation of supply agreements for certain raw materials in Performance Materials and Technologies and Honeywell Building Technologies and closure obligations associated with site transitions.

The following table summarizes the status of the Company's total repositioning reserves:


	Severance Costs		Asset Impairments		Exit Costs		Total
December 31, 2019	$	555	$	—	$	96	$	651
Charges	433		11		47		491
Usage - cash	(343)		—		(56)		(399)
Usage - noncash	—		(11)		—		(11)
Foreign currency translation	9		—		—		9
Adjustments	(40)		—		(2)		(42)
September 30, 2020	$	614	$	—	$	85	$	699

Certain repositioning projects will recognize exit costs in future periods when the actual liability is incurred. Such exit costs incurred in the nine months ended September 30, 2020 and 2019 were $32 million and $21 million, respectively.

PENSION BENEFITS

9 Months Ended

Sep. 30, 2020

Retirement Benefits, Description [Abstract]

Pension Benefits

Note 15. Pension Benefits

Net periodic pension benefit costs for the Company's significant defined benefit plans include the following components:


	U.S. Plans
	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Service cost	$	25	$	21	$	74	$	63
Interest cost	116		153		346		460
Expected return on plan assets	(284)		(279)		(851)		(837)
Amortization of prior service (credit)	(11)		(11)		(32)		(33)
	$	(154)	$	(116)	$	(463)	$	(347)


	Non-U.S. Plans
	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Service cost	$	6	$	4	$	17	$	16
Interest cost	26		34		78		106
Expected return on plan assets	(84)		(81)		(249)		(248)
Amortization of prior service (credit)	—		—		—		—
	$	(52)	$	(43)	$	(154)	$	(126)

During the three months ended September 30, 2020, the Company did not purchase any Honeywell shares from the Honeywell U.S. Pension Plan Master Trust. During the nine months ended September 30, 2020, the Company repurchased $100 million of outstanding Honeywell shares from the Honeywell U.S. Pension Plan Master Trust. During the three and nine months ended September 30, 2019, the Company repurchased $100 million and $300 million of outstanding Honeywell shares from the Honeywell U.S. Pension Plan Master Trust.

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Net Sales	$ 7,797	$ 9,086	$ 23,737	$ 27,213
Disaggregation of revenue, timing of recognition - percentage	100.00%	100.00%	100.00%	100.00%
Products [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 5,885	$ 6,793	$ 17,933	$ 20,496
Disaggregation of revenue, timing of recognition - percentage	76.00%	75.00%	76.00%	75.00%
Products [Member] \| Transferred At Point In Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	61.00%	62.00%	61.00%	61.00%
Products [Member] \| Transferred Over Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	15.00%	13.00%	15.00%	14.00%
Services [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 1,912	$ 2,293	$ 5,804	$ 6,717
Disaggregation of revenue, timing of recognition - percentage	24.00%	25.00%	24.00%	25.00%
Services [Member] \| Transferred At Point In Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	7.00%	8.00%	8.00%	9.00%
Services [Member] \| Transferred Over Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	17.00%	17.00%	16.00%	16.00%
Aerospace
Disaggregation of Revenue [Line Items]
Net Sales	$ 2,662	$ 3,544	$ 8,566	$ 10,393
Aerospace \| Commercial Aviation Original Equipment [Member]
Disaggregation of Revenue [Line Items]
Net Sales	406	772	1,527	2,265
Aerospace \| Commercial Aviation Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Net Sales	774	1,452	2,807	4,234
Aerospace \| Defense and Space [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,482	1,320	4,232	3,894
Honeywell Building Technologies
Disaggregation of Revenue [Line Items]
Net Sales	1,305	1,415	3,763	4,254
Honeywell Building Technologies \| Products [Member]
Disaggregation of Revenue [Line Items]
Net Sales	751	823	2,163	2,476
Honeywell Building Technologies \| Building Solutions [Member]
Disaggregation of Revenue [Line Items]
Net Sales	554	592	1,600	1,778
Performance Materials and Technologies
Disaggregation of Revenue [Line Items]
Net Sales	2,252	2,670	6,867	7,977
Performance Materials and Technologies \| UOP [Member]
Disaggregation of Revenue [Line Items]
Net Sales	461	717	1,572	2,030
Performance Materials and Technologies \| Process Solutions [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,135	1,283	3,379	3,818
Performance Materials and Technologies \| Specialty Products [Member]
Disaggregation of Revenue [Line Items]
Net Sales	261	256	786	790
Performance Materials and Technologies \| Fluorine Products [Member]
Disaggregation of Revenue [Line Items]
Net Sales	395	414	1,130	1,339
Safety and Productivity Solutions
Disaggregation of Revenue [Line Items]
Net Sales	1,578	1,457	4,541	4,589
Safety and Productivity Solutions \| Safety and Retail [Member]
Disaggregation of Revenue [Line Items]
Net Sales	599	558	1,612	1,653
Safety and Productivity Solutions \| Productivity Solutions and Services [Member]
Disaggregation of Revenue [Line Items]
Net Sales	322	307	877	926
Safety and Productivity Solutions \| Warehouse and Workflow Solutions [Member]
Disaggregation of Revenue [Line Items]
Net Sales	445	383	1,457	1,361
Safety and Productivity Solutions \| Sensing & Internet-of-Things (IoT)
Disaggregation of Revenue [Line Items]
Net Sales	$ 212	$ 209	$ 595	$ 649

ACCOUNTS RECEIVABLE - NET (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]
Trade	$ 7,064	$ 7,639
Less - Allowance for doubtful accounts	(186)	(146)
Accounts receivable, Net	6,878	7,493
Accounts Notes And Other Receivables Paragraph Details [Abstract]
Unbilled contracts receivable	$ 1,779	$ 1,586

BASIS OF PRESENTATION	9 Months Ended
BASIS OF PRESENTATION	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Text Block]	Note 1. Basis of Presentation In the opinion of management, the accompanying unaudited Consolidated Financial Statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of Honeywell International Inc. and its consolidated subsidiaries (“Honeywell” or “the Company”) at September 30, 2020 and December 31, 2019, the cash flows for the nine months ended September 30, 2020 and September 30, 2019 and the results of operations for the three and nine months ended September 30, 2020 and September 30, 2019. The results of operations for the three and nine months ended September 30, 2020 and cash flows for the nine months ended September 30, 2020 should not necessarily be taken as indicative of the entire year. Honeywell reports its quarterly financial information using a calendar convention; the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been Honeywell's practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires Honeywell's businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on our business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. In the event that differences in actual closing dates are material to year-over-year comparisons of quarterly or year-to-date results, Honeywell will provide appropriate disclosures. Honeywell's actual closing dates for the three and nine months ended September 30, 2020 and September 30, 2019 were September 26, 2020 and September 28, 2019.

LONG-TERM DEBT AND CREDIT AGREEMENTS (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Long-Term Debt


	September 30, 2020		December 31, 2019

0.65% Euro notes due 2020	$	—	$	1,123
4.25% notes due 2021	800		800
1.85% notes due 2021	1,500		1,500
0.483% notes due 2022	2,500		—
2.15% notes due 2022	600		600
Floating rate notes due 2022	1,100		600
1.30% Euro notes due 2023	1,454		1,404
3.35% notes due 2023	300		300
0.00% Euro notes due 2024	582		—
2.30% notes due 2024	750		750
1.35% notes due 2025	1,250		—
2.50% notes due 2026	1,500		1,500
2.25% Euro notes due 2028	872		842
2.70% notes due 2029	750		750
1.95% notes due 2030	1,000		—
0.75% Euro notes due 2032	582		—
5.70% notes due 2036	441		441
5.70% notes due 2037	462		462
5.375% notes due 2041	417		417
3.812% notes due 2047	445		445
2.80% notes due 2050	750		—
Industrial development bond obligations, floating rate maturing at various dates through 2037	22		22
6.625% debentures due 2028	201		201
9.065% debentures due 2033	51		51
Other (including capitalized leases and debt issuance costs), 8.0% weighted average maturing at various dates through 2025	343		278
	18,672		12,486
Less: current portion	(985)		(1,376)
	$	17,687	$	11,110

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

PENSION BENEFITS (Details) - USD ($)	3 Months Ended		9 Months Ended
PENSION BENEFITS (Details) - USD ($)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Defined Benefit Plan Disclosure [Line Items]
Payments for Repurchase of Common Stock			$ 2,149,000,000	$ 3,650,000,000
United States, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Payments for Repurchase of Common Stock		$ 100,000,000	100,000,000	300,000,000
Service cost	$ 25,000,000	21,000,000	74,000,000	63,000,000
Interest cost	116,000,000	153,000,000	346,000,000	460,000,000
Expected return on plan assets	(284,000,000)	(279,000,000)	(851,000,000)	(837,000,000)
Amortization of prior service (credit)	(11,000,000)	(11,000,000)	(32,000,000)	(33,000,000)
Net periodic benefit (income)	(154,000,000)	(116,000,000)	(463,000,000)	(347,000,000)
Non-US, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	6,000,000	4,000,000	17,000,000	16,000,000
Interest cost	26,000,000	34,000,000	78,000,000	106,000,000
Expected return on plan assets	(84,000,000)	(81,000,000)	(249,000,000)	(248,000,000)
Amortization of prior service (credit)	0	0	0	0
Net periodic benefit (income)	$ (52,000,000)	$ (43,000,000)	$ (154,000,000)	$ (126,000,000)

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Accumulated Other Comprehensive Income Loss [Line Items]
Balance at beginning of period	$ 18,706,000,000
Balance at end of period	18,313,000,000	$ 18,306,000,000
Foreign Exchange Translation Adjustment [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance at beginning of period	(2,566,000,000)	(2,709,000,000)
Other comprehensive income (loss) before reclassifications	(227,000,000)	188,000,000
Amounts reclassified from accumulated other comprehensive income	(10,000,000)	(11,000,000)
Net current period other comprehensive income (loss)	(237,000,000)	177,000,000
Balance at end of period	(2,803,000,000)	(2,532,000,000)
Pension and Other Postretirement Benefits Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance at beginning of period	(675,000,000)	(761,000,000)
Other comprehensive income (loss) before reclassifications	0	0
Amounts reclassified from accumulated other comprehensive income	(60,000,000)	(59,000,000)
Net current period other comprehensive income (loss)	(60,000,000)	(59,000,000)
Balance at end of period	(735,000,000)	(820,000,000)
Changes in Fair Value of Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance at beginning of period	44,000,000	33,000,000
Other comprehensive income (loss) before reclassifications	50,000,000	110,000,000
Amounts reclassified from accumulated other comprehensive income	8,000,000	(86,000,000)
Net current period other comprehensive income (loss)	58,000,000	24,000,000
Balance at end of period	102,000,000	57,000,000
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance at beginning of period	(3,197,000,000)	(3,437,000,000)
Other comprehensive income (loss) before reclassifications	(177,000,000)	298,000,000
Amounts reclassified from accumulated other comprehensive income	(62,000,000)	(156,000,000)
Net current period other comprehensive income (loss)	(239,000,000)	142,000,000
Balance at end of period	$ (3,436,000,000)	$ (3,295,000,000)

SEGMENT FINANCIAL DATA

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Segment Financial Data

Note 14. Segment Financial Data

Honeywell globally manages our business operations through four reportable operating segments. Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions and assesses operating performance.

Honeywell’s senior management evaluates segment performance based on segment profit. Each segment’s profit is measured as segment income (loss) before taxes excluding general corporate unallocated expense, interest and other financial charges, stock compensation expense, pension and other postretirement income (expense), repositioning and other charges, and other items within Other (income) expense.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Net sales
Aerospace
Products	$	1,623	$	2,213	$	5,335	$	6,462
Services	1,039		1,331		3,231		3,931
Total	2,662		3,544		8,566		10,393
Honeywell Building Technologies
Products	972		1,091		2,807		3,283
Services	333		324		956		971
Total	1,305		1,415		3,763		4,254
Performance Materials and Technologies
Products	1,803		2,129		5,510		6,437
Services	449		541		1,357		1,540
Total	2,252		2,670		6,867		7,977
Safety and Productivity Solutions
Products	1,487		1,360		4,281		4,314
Services	91		97		260		275
Total	1,578		1,457		4,541		4,589
	$	7,797	$	9,086	$	23,737	$	27,213
Segment profit
Aerospace	$	617	$	908	$	2,082	$	2,653
Honeywell Building Technologies	282		297		794		868
Performance Materials and Technologies	442		582		1,373		1,790
Safety and Productivity Solutions	219		195		610		598
Corporate	(7)		(54)		(73)		(202)
Total segment profit	1,553		1,928		4,786		5,707
Interest and other financial charges	(101)		(96)		(264)		(266)
Stock compensation expense(a)	(40)		(37)		(118)		(112)
Pension ongoing income(b)	197		150		593		449
Other postretirement income(b)	13		12		40		35
Repositioning and other charges(c)	(144)		(96)		(486)		(306)
Other(d)	(330)		106		(249)		284
Income before taxes	$	1,148	$	1,967	$	4,302	$	5,791

(a) Amounts included in Selling, general and administrative expenses.

(b) Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service costs) and Other income/expense (non-service cost components).

(c) Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other income/expense.(d) Amounts include the other components of Other income/expense not included within other categories in this reconciliation. Equity income/loss of affiliated companies is included in segment profit.

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES 5 (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Revenue	$ 7,797,000,000	$ 9,086,000,000	$ 23,737,000,000	$ 27,213,000,000
Cost of products and services sold	5,383,000,000	6,038,000,000	16,193,000,000	18,011,000,000
SG&A	1,103,000,000	1,296,000,000	3,524,000,000	4,046,000,000
Other (income) expense	62,000,000	(311,000,000)	(546,000,000)	(901,000,000)
Interest and other financial charges	101,000,000	96,000,000	264,000,000	266,000,000
Designated as Hedging Instrument [Member] \| Foreign currency exchange contracts [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss)	(28,000,000)	23,000,000	(46,000,000)	28,000,000
Designated as Hedging Instrument [Member] \| Gain or (loss) on cash flow hedges [Member] \| Foreign currency exchange contracts [Member] \| Revenue [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	(1,000,000)	1,000,000	(2,000,000)	2,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on cash flow hedges [Member] \| Foreign currency exchange contracts [Member] \| Cost of Products Sold [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	(1,000,000)	9,000,000	29,000,000	33,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	4,000,000	6,000,000	12,000,000	17,000,000
Designated as Hedging Instrument [Member] \| Gain or (loss) on cash flow hedges [Member] \| Foreign currency exchange contracts [Member] \| SG&A [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	(1,000,000)	0	(4,000,000)	1,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on cash flow hedges [Member] \| Foreign currency exchange contracts [Member] \| Other (income) Expense [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	(35,000,000)	53,000,000	(37,000,000)	77,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	8,000,000	9,000,000	25,000,000	27,000,000
Designated as Hedging Instrument [Member] \| Gain or (loss) on cash flow hedges [Member] \| Foreign currency exchange contracts [Member] \| Interest and Other Financial Charges [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	0	0	0	0
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges \| Interest Rate Swap [Member] \| Revenue [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0	0	0
Derivatives designated as hedges	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges \| Interest Rate Swap [Member] \| Cost of Products Sold [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0	0	0
Derivatives designated as hedges	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges \| Interest Rate Swap [Member] \| SG&A [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0	0	0
Derivatives designated as hedges	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges \| Interest Rate Swap [Member] \| Other (income) Expense [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0	0	0
Derivatives designated as hedges	0	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges \| Interest Rate Swap [Member] \| Interest and Other Financial Charges [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	13,000,000	(55,000,000)	(206,000,000)	(118,000,000)
Derivatives designated as hedges	(13,000,000)	55,000,000	206,000,000	118,000,000
Designated as Hedging Instrument [Member] \| Euro denominated long-term debt [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss)	(126,000,000)	131,000,000	(64,000,000)	157,000,000
Designated as Hedging Instrument [Member] \| Net Investment Euro Denominated Commercial Paper [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss)	(25,000,000)	136,000,000	30,000,000	163,000,000
Designated as Hedging Instrument [Member] \| Net Investment Cross Currency Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss)	(42,000,000)	39,000,000	(61,000,000)	44,000,000
Products [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Revenue	5,885,000,000	6,793,000,000	17,933,000,000	20,496,000,000
Cost of products and services sold	$ 4,315,000,000	$ 4,775,000,000	$ 12,852,000,000	$ 14,244,000,000

REPOSITIONING AND OTHER CHARGES 2 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Pretax Distribution Of Total Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	$ 144	$ 96	$ 486	$ 306
Cost of products and services sold [Member]
Pretax Distribution Of Total Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	91	75	286	204
Selling, general and administrative expenses [Member]
Pretax Distribution Of Total Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	$ 53	$ 21	$ 200	$ 102

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Accrual for Environmental Loss Contingencies [Roll Forward]
Beginning of period	$ 709
Accruals for environmental matters deemed probable and reasonably estimable	127
Environmental liability payments	(166)
Other	(4)
End of period	666
Loss Contingency, Classification of Accrual [Abstract]
Accrued liabilities	222	$ 222
Other liabilities	444	487
Total environmental liabilities	$ 666	$ 709

COMMITMENTS AND CONTINGENCIES 6 (Details) - Bendix Asbestos Loss Contingency Liability [Member] - claim	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Loss Contingency Disease Distribution Of Unresolved Claims [Line Items]
Mesothelioma and other cancer claims	3,404	3,399	2,949
Nonmalignant claims	3,017	3,081	3,260
Total claims	6,421	6,480	6,209	6,280

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Loss Contingency

The following table summarizes information concerning our recorded liabilities for environmental costs:


December 31, 2019	$	709
Accruals for environmental matters deemed probable and reasonably estimable	127
Environmental liability payments	(166)
Other	(4)
September 30, 2020	$	666

Environmental liabilities are included in the following balance sheet accounts:


	September 30, 2020		December 31, 2019
Accrued liabilities	$	222	$	222
Other liabilities	444		487
	$	666	$	709

Asbestos Related Liabilities


Asbestos-Related Liabilities
	Bendix		NARCO		Total
December 31, 2019	$	1,499	$	858	$	2,357
Accrual for update to estimated liability	45		14		59
Asbestos related liability payments	(143)		(67)		(210)
September 30, 2020	$	1,401	$	805	$	2,206

Insurance Recoveries for Asbestos Related Liabilities


Insurance Recoveries for Asbestos-Related Liabilities
	Bendix		NARCO		Total
December 31, 2019	$	153	$	281	$	434
Probable insurance recoveries related to estimated liability	—		—		—
Insurance receipts for asbestos-related liabilities	(10)		(7)		(17)
Insurance receivables settlements	—		(1)		(1)
September 30, 2020	$	143	$	273	$	416

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts

NARCO and Bendix asbestos-related balances are included in the following balance sheet accounts:


	September 30, 2020		December 31, 2019
Other current assets	$	42	$	42
Insurance recoveries for asbestos-related liabilities	374		392
	$	416	$	434
Accrued liabilities	$	361	$	361
Asbestos-related liabilities	1,845		1,996
	$	2,206	$	2,357

The following tables present information regarding Bendix related asbestos claims activity


	Nine Months Ended September 30,	Years Ended December 31,
Claims Activity	2020	2019	2018
Claims unresolved at the beginning of period	6,480	6,209	6,280
Claims filed	1,621	2,659	2,430
Claims resolved	(1,680)	(2,388)	(2,501)
Claims unresolved at the end of period	6,421	6,480	6,209

Disease distribution of claims


Disease Distribution of Unresolved Claims	September 30,	December 31,
	2020	2019	2018
Mesothelioma and other cancer claims	3,404	3,399	2,949
Nonmalignant claims	3,017	3,081	3,260
Total claims	6,421	6,480	6,209

Average resolution values per asbestos claim

Honeywell has experienced average resolution values per claim excluding legal costs as follows:


	Years Ended December 31,
	2019		2018		2017		2016		2015
	(in whole dollars)
Malignant claims	$	50,200	$	55,300	$	56,000	$	44,000	$	44,000
Nonmalignant claims	$	3,900	$	4,700	$	2,800	$	4,485	$	100

Indemnification And Reimbursement Agreement

As of September 30, 2020, the Company’s receivables prior to the adjustments described herein from Garrett and/or certain of its subsidiaries were collectively as follows:


	September 30, 2020
Garrett Indemnification and Reimbursement	$	1,121
Tax Matters Agreement	273
Other Receivables, net	13
Total Reimbursement Receivables	$	1,407

COMMITMENTS AND CONTINGENCIES 9 (Details) - USD ($)	3 Months Ended		9 Months Ended
COMMITMENTS AND CONTINGENCIES 9 (Details) - USD ($)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Garrett Bankruptcy Proposals [Line Items]
Reimbursement Receivables Charge	$ 350,000,000	$ 0	$ 350,000,000	$ 0
Garrett Indemnification And Reimbursement Receivables [Member]
Garrett Bankruptcy Proposals [Line Items]
Reimbursement Receivables Charge			350,000,000
Reimbursement Receivables	1,400,000,000		1,400,000,000
Share And Asset Purchase Agreement [Member]
Garrett Bankruptcy Proposals [Line Items]
Proposed Purchase Price	2,600,000,000		2,600,000,000
Current Stockholders Common Stock Co-investment Amount	350,000,000		350,000,000
Bidding Protections Termination Fee			63,000,000
Bidding Protections Expense Reimbursement Maximum Amount			21,000,000
Oaktree And Centerbridge Coordination Agreement [Member]
Garrett Bankruptcy Proposals [Line Items]
Cash Received By Honeywell	1,450,000,000		1,450,000,000
Oaktree And Centerbridge Coordination Agreement [Member] \| Initial Payment [Member]
Garrett Bankruptcy Proposals [Line Items]
Cash Received By Honeywell	275,000,000		275,000,000
Oaktree And Centerbridge Coordination Agreement [Member] \| Payment Over Time [Member]
Garrett Bankruptcy Proposals [Line Items]
Cash Received By Honeywell	$ 1,175,000,000		$ 1,175,000,000

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fair Value Measurements Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale investments	$ 1,160,000,000	$ 1,523,000,000
Foreign currency exchange contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amount of hedged item	694,000,000	3,513,000,000
Foreign currency exchange contracts [Member] \| Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	357,000,000	291,000,000
Derivative Fair Value Of Derivative Liability	34,000,000	21,000,000
Interest rate swap agreements [Member] \| Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	230,000,000	38,000,000
Derivative Fair Value Of Derivative Liability	0	13,000,000
Cross currency swap agreements [Member] \| Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	$ 10,000,000	$ 51,000,000

SEGMENT FINANCIAL DATA (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Segment Financial Data


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Net sales
Aerospace
Products	$	1,623	$	2,213	$	5,335	$	6,462
Services	1,039		1,331		3,231		3,931
Total	2,662		3,544		8,566		10,393
Honeywell Building Technologies
Products	972		1,091		2,807		3,283
Services	333		324		956		971
Total	1,305		1,415		3,763		4,254
Performance Materials and Technologies
Products	1,803		2,129		5,510		6,437
Services	449		541		1,357		1,540
Total	2,252		2,670		6,867		7,977
Safety and Productivity Solutions
Products	1,487		1,360		4,281		4,314
Services	91		97		260		275
Total	1,578		1,457		4,541		4,589
	$	7,797	$	9,086	$	23,737	$	27,213
Segment profit
Aerospace	$	617	$	908	$	2,082	$	2,653
Honeywell Building Technologies	282		297		794		868
Performance Materials and Technologies	442		582		1,373		1,790
Safety and Productivity Solutions	219		195		610		598
Corporate	(7)		(54)		(73)		(202)
Total segment profit	1,553		1,928		4,786		5,707
Interest and other financial charges	(101)		(96)		(264)		(266)
Stock compensation expense(a)	(40)		(37)		(118)		(112)
Pension ongoing income(b)	197		150		593		449
Other postretirement income(b)	13		12		40		35
Repositioning and other charges(c)	(144)		(96)		(486)		(306)
Other(d)	(330)		106		(249)		284
Income before taxes	$	1,148	$	1,967	$	4,302	$	5,791

(a) Amounts included in Selling, general and administrative expenses.

(b) Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service costs) and Other income/expense (non-service cost components).

Reconciliation of Operating Profit Loss From Segments to Consolidated


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Net sales
Aerospace
Products	$	1,623	$	2,213	$	5,335	$	6,462
Services	1,039		1,331		3,231		3,931
Total	2,662		3,544		8,566		10,393
Honeywell Building Technologies
Products	972		1,091		2,807		3,283
Services	333		324		956		971
Total	1,305		1,415		3,763		4,254
Performance Materials and Technologies
Products	1,803		2,129		5,510		6,437
Services	449		541		1,357		1,540
Total	2,252		2,670		6,867		7,977
Safety and Productivity Solutions
Products	1,487		1,360		4,281		4,314
Services	91		97		260		275
Total	1,578		1,457		4,541		4,589
	$	7,797	$	9,086	$	23,737	$	27,213
Segment profit
Aerospace	$	617	$	908	$	2,082	$	2,653
Honeywell Building Technologies	282		297		794		868
Performance Materials and Technologies	442		582		1,373		1,790
Safety and Productivity Solutions	219		195		610		598
Corporate	(7)		(54)		(73)		(202)
Total segment profit	1,553		1,928		4,786		5,707
Interest and other financial charges	(101)		(96)		(264)		(266)
Stock compensation expense(a)	(40)		(37)		(118)		(112)
Pension ongoing income(b)	197		150		593		449
Other postretirement income(b)	13		12		40		35
Repositioning and other charges(c)	(144)		(96)		(486)		(306)
Other(d)	(330)		106		(249)		284
Income before taxes	$	1,148	$	1,967	$	4,302	$	5,791

(a) Amounts included in Selling, general and administrative expenses.

(b) Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service costs) and Other income/expense (non-service cost components).

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS 2 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Jan. 01, 2020	Jan. 01, 2019
Change in Contract with Customer, Asset and Liability [Abstract]
Contract Assets	$ 1,819	$ 1,812	$ 1,819	$ 1,812	$ 1,602	$ 1,548
Change in Contract Assets - Increase (Decrease)			217	264
Contract Liabilities	(3,666)	(3,188)	(3,666)	(3,188)	$ (3,501)	$ (3,378)
Change in Contract Liabilities - (Increase) Decrease			(165)	190
Net Change			52	454
Contract liability, revenue recognized	$ 351	$ 215	$ 1,554	$ 1,195